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Proline is a unique and important amino acid. Proline is a proteogenic amino 
acid and its metabolism is involved in many critical cellular functions. Therefore, 
proline metabolism is tightly regulated, and dysfunction of proline metabolism is 
related to human diseases. The first step of proline oxidization to ∆1-pyrroline-5-
carboxylic acid (P5C) is catalyzed by proline dehydrogenase (PRODH). P5C is 
then non-enzymatically hydrolyzed to glutamate-γ-semialdehyde (GSA), which 
can be further oxidized to glutamate by P5C dehydrogenase (P5CDH/GSALDH). 
In Gram-negative bacteria, the PRODH and P5CDH enzymes are expressed as 
one polypeptide called proline utilization A (PutA). In some Gram-negative bacteria 
an additional ribbon-helix-helix (RHH) domain is at the N-terminus of PutA, thus 
imparting additional DNA-binding activity. 
The PutA RHH domain recognizes putC, which is the intergenic DNA between 
the genes putP (encodes for a proline transporter) and putA (encodes for PutA). 
Thus, the trifunctional PutAs regulate their own gene expression and proline 
transport by sensing cellular proline levels. A linker region connecting the DNA 
binding domain and the PRODH domain is believed to be important for PutA to 
switch function from DNA binding to membrane binding. A detailed study of the 




 Two natural thiol-containing proline analogs, the thiazolidine-2-carboxylic acid 
(T2C) and thiazolidine-4-carboxylic acid (T4C), have been reported to have 
beneficial and toxic effects in different organisms. In Chapter 3, T2C and T4C are 
tested as substrates using the bifunctional PutA enzyme from Sinorhizobium 
meliloti (SmPutA) as model for proline catabolic enzymes. X-ray crystal structures 
of SmPutA in complex with thioproline analogs are available, making SmPutA ideal 
for enzymatic characterization with thioprolines.  
The PRODH and P5CDH/GSALDH domains are physically close to each other 
in bifunctional PutAs, and tunnels have been found connecting both active sites, 
allowing direct translocation of P5C/GSA from PRODH to P5CDH/GSALDH. 
Chapter 4 presents kinetic characterization of SmPutA wild-type and site-specific 
mutants, including a tunnel blocking mutant, and two monofunctional SmPutA 
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Chapter 1. Introduction 
1.1 Proline metabolism and related enzymes 
 
 
Figure 1. Proline metabolic pathway and enzymes. Adapted from “Role of proline 
in pathogen and host interactions”19. Abbreviations: αKG for alpha ketoglutarate, 
CoQ for coenzyme Q, CoQH2 for reduced CoQ, FAD for oxidized flavin, FADH2 for 
2 electron reduced flavin, γGK for γ-glutamyl kinase, γGPR  for γ-glutamyl 
phosphate reductase, GLU for glutamate, GSA for glutamate- γ-semialdehyde, 
NAD(P)+ for oxidized nicotinamide adenine dinucleotide (phosphate), NAD(P)H for 
reduced nicotinamide adenine dinucleotide (phosphate), OAT for ornithine 
aminotransferase, ORN for ornithine, P5C for ∆1-pyrroline-5-carboxylic acid, 
P5CDH for pyrroline-5-carboxylic acid dehydrogenase or glutamate-gamma-
semialdehyde dehydrogenase, P5CS for P5C synthase, P5CR for P5C reductase, 






Proline is of special interest in different areas of study due to its roles in a variety 
of important cellular functions among various species. Proline can be used as an 
energy source1–3, and in some bacteria, proline can serve as the only carbon and 
nitrogen source. Proline balances redox homeostasis4,5, response to stress6–11, 
promotes pathogen virulence12–14 and, influences apoptotic15 and cell survival 
pathways16. Proline has also proven to extend worm lifespan4 and affect 
tumorigenesis in mammals17,18, and proline is one of the protein-building amino 
acids.  
 Figure 1 shows the enzymes and reactions of the proline metabolic pathway. 
The first step of proline biosynthesis is the phosphorylation of glutamate by ATP-
dependent γ-glutamyl kinase (γGK), which in bacteria such as Escherichia coli is 
encoded by proB. The phosphorylated glutamate is then reduced to glutamate-γ-
semialdehyde (GSA) by NADPH-dependent γ-glutamyl phosphate reductase 
(γGPR) encoded by the proA gene E. coli20,21. The γGK enzyme is negative 
feedback regulated by proline22. In animals and plants, the reduction of glutamate 
to GSA by γGK and γGPR is catalyzed by a single enzyme called P5C synthase 
(P5CS)20,23. GSA spontaneously cyclizes to Δ1-pyrroline-5-carboxylate (P5C), 
which is then reduced to proline by P5C reductase (P5CR or PYCR) using 
NAD(P)H as the hydride donor. In some organisms, proline can alternatively be 
synthesized from arginine via ornithine and ornithine aminotransferase (OAT)20.  
 The first step of proline oxidization is universally conserved through FAD-
dependent proline dehydrogenase (PRODH)/proline oxidase (POX), which 
converts proline to Δ1-pyrroline-5-carboxylic acid (P5C)24. In this reaction, 
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electrons from proline are ultimately delivered to the electron transport chain to 
generate reduced ubiquinone (QH2) (Figure 1). In prokaryotes, PRODH must 
associate with the cytoplasmic membrane to catalyze proline oxidation and in 
eukaryotes, PRODH is bound to the inner mitochondrial membrane. The hydrolysis 
product of P5C, L-glutamate-γ-semialdehyde (GSAL) is further oxidized to 
glutamate by L-glutamate-γ-semialdehyde dehydrogenase (GSALDH) or 
sometimes referred to as Δ1-pyrroline-5-carboxylic acid dehydrogenase (P5CDH), 
which utilizes NADH as a cofactor24. Glutamate can enter the TCA cycle as α-
ketoglutarate. At the same time, the intermediate P5C can be converted to 
ornithine by ornithine aminotransferase (OAT)25. Therefore, proline metabolism is 
linked to two critical pathways: the TCA cycle via glutamate and the urea cycle via 
ornithine26.  
1.2 Proline metabolism-related disorders 
Proline metabolism is regulated by several enzymes and is directly connected 
to critical cellular pathways as noted above and the pentose phosphate pathway. 
Besides the aforementioned pathways, proline is critical for connective tissues and 
is the building block of 4-hydroxyproline, the most abundant amino acid in collagen. 
These factors along with proline oxidation and biosynthesis being localized in the 
mitochondrion, are some of the underlying reasons why errors in proline 
metabolism are related to various human diseases.  
 In humans, POX or PRODH is located at 22q11.2127, and GSALDH (P5CDH 
or ALDH4A1) is at 1p3627. Deficiencies in PRODH and GSALDH lead to type I 
hyperprolinemia28 and type II hyperprolinemia29, respectively. At least 16 missense 
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PRODH mutations have been identified that lead to hyperprolinemia30. Evidence 
suggests PRODH deficiency is linked to schizophrenia31–33, while type II 
hyperprolinemia caused by P5CDH deficiency leads to vitamin B6 inactivation 
resulting in seizures34,35. In addition to inborn errors, upregulation of proline 
metabolism has been found in different cancers26,36, with down-regulation of 
proline metabolism being shown to inhibit cancer cell growth and protein 
synthesis37. 
 
1.3 Proline utilization A 
 
  
 In Gram-negative bacteria, PRODH and P5CDH/GSALDH are transcribed as 
the same polypeptide called proline utilization A (PutA). These bi-functional PutAs 
are classified into type A or type B PutAs (see Figure 2) based on if there is an 
additional aldehyde dehydrogenase superfamily domain at the C terminal38. PutA 
from Sinorhizobium meliloti (SmPutA) has the best-resolved crystal structure 
resolution of a type B PutA. Interestingly, in some Gram-negative bacteria such as 
E. coli, there is an additional DNA binding domain at the N-terminal of PutAs that 
Figure 2. Domain architecture of PutAs. Adapted from “Structure and 
characterization of a class 3B proline utilization A: Ligand-induced dimerization and 
importance of the C-terminal domain for catalysis” by Korasick, David A., 
Thameesha T. Gamage, Shelbi Christgen, Kyle M. Stiers, Lesa J. Beamer, Michael 
T. Henzl, Donald F. Becker, and John J. Tanner. Journal of Biological 
Chemistry 292, no. 23 (2017): 9652-9665. 
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is responsible for regulating PutA expression (Figure 2). These tri-functional PutAs 
are classified as type C PutAs38 with the best studied example being PutA from E. 
coli (EcPutA). SmPutA and EcPutA, type B and C PutAs respectively, share 60% 
sequence identity and 72% similarity (NCBI Blast). The major difference between 
these two PutAs is the presence of the DNA-binding domain at the N-terminus of 
EcPutA.  
 The expression of EcPutA is regulated by the proline utilization regulon (put 
regulon) which contains two protein coding genes called putP and putA and one 
regulatory region called putC. The putP gene encodes the high-affinity Na+/proline 
transporter39, and putA encodes EcPutA itself. The N-terminal DNA binding 
domain from EcPutA is a ribbon-helix-helix domain (RHH). The RHH domain 
recognizes and binds to the intergenic putC region at five specific sites40. Under 
proline deprived conditions, EcPutA suppresses the expression of both putP and 
putA by binding to the putC region and preventing the initiation of the transcription41. 
Upon accumulation of proline, putP and putA gene expression is upregulated as 
EcPutA translocates from the DNA to the membrane. The reduction of the FAD 
cofactor in the PRODH domain triggers a conformational change that favors 
membrane binding of EcPutA42. The switching from DNA binding to membrane 
association is referred to as functional switching. In addition to relieving repression 
of the put genes, EcPutA-membrane binding is necessary for coupling proline 





Figure 3. Structure of EcPutA 86-669 active site with L-THFA bound (PDB 1TIW). (A) Front 
and (B) side view of the flavin cofactor and surrounding active site residues. Adapted from 
“Structures of the Escherichia coli PutA proline dehydrogenase domain in complex with 
competitive inhibitors” by Min Zhang, Tommi A White, Jonathan P. Schuermann, Berevan 







 EcPutA and SmPutA have been useful models to understand the mechanism 
of proline oxidization. Even though the sequence similarity between the EcPutA 
PRODH domain and human PRODH is only 20%, the similarity in active site 
residues between the two proteins is 62%. The high sequence similarity in the 
active site regions suggests a similar active site fold and catalytic mechanism 
between human PRODH and EcPutA44.  
 The PRODH domain of EcPutA and SmPutA has a triose-phosphate isomerase 
(TIM) barrel structure that consists of 8 β-sheets and 8 α-helices wrapping around 
as a barrel. At the core of the barrel is the flavin adenine dinucleotide (FAD) 
cofactor and the proline binding site45. Crystal structures of proline bound to the 
PRODH active site are not available. However, crystal structures of EcPutA and 
SmPutA in complex with the PRODH competitive inhibitor, L-tetrahydro-2-furoic 
acid (L-THFA), have provided key insights into the proline binding site and reaction 
mechanism. Figure 3 (panel A) shows L-THFA complexed to the PRODH active 
site of EcPutA. Proline is thought to bind in a similar manner near the FAD enabling 
hydride transfer from the C5 atom of proline to the N5 of the FAD (Figure 3A). A 
structure was also solved with propargylglycine covalently linked to the N5 of FAD 
(not shown). This covalent modification mimics the reduced FAD conformation 
which involves a significant butterfly bend of the isoalloxazine ring and 
conformational changes in the ribityl side chain of the FAD46. As shown in Figure 
3A, Arg556 makes ion pair interactions with the ligand molecule. Mutation of 
Arg556 (e.g., R556M) in EcPutA confirmed Arg556 has a critical role in catalysis 
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and proline binding as the EcPutAR556M mutant is devoid of PRODH activity47. 
The function of several residues near the active site has also been studied by site-
specific mutagenesis. For instance, a L432P mutant of EcPutA was made to study 
the L441P polymorphism found in human PRODH. Mutation of Leu432 to Pro 
significantly decreases EcPutA thermal stability by disrupting the interaction 
around the hydrophobic core44 providing insights into the clinical observations of 
the L441P mutant in patients (Figure 3B). 
 
1.4 Enzyme allosteric effects 
1.4.1 A brief history and introduction of enzyme allostery 
Enzyme allostery refers to the regulation at another site that is distant from the 
active site. Such phenomenon was first described in 1904 when Christian Bohr 
observed that carbon dioxide affects the binding of oxygen to hemoglobin48. 
Therefore it was called the Bohr effect until 1961 when the word “allosteric” was 
coined to describe the non-steric mechanism of inhibition49.  
The two well-accepted models of enzyme allostery are the concerted Monod-
Wyman-Changeux (MWC)50 and sequential Koshland-Nemethy-Filmer (KNF)51 
model. The concerted MWC model postulates that the subunits of an enzyme all 
stay in one state, and that the change of state of one subunit, caused by the binding 
of their substrates, will induce a state change to all other subunits. The sequential 
KNF model, on the other hand, postulates that the change of state of the subunits 
is not synchronized, that is, the state of all the subunits may not be the same. In 
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1984, Cooper and Dryden presented an allostery model which takes the thermal 
fluctuation or entropy effect into account and showed that a conformational change 
is not required52. This theory was questioned three decades later by the Nussinov 
group53 who did great contributions by pushing the allostery field forward. Nussinov 
and his group published a series of papers that proposed a “conformational 
selection and population shift” model which is been widely used to explain 
allostery54–56. This model proposed there are “a range of conformations” rather 
than just two known as the relaxed and tense states.  
1.4.2 Methods for enzyme allostery studies 
A powerful method for studying enzyme allostery is X-ray crystallography. 
Crystal structures can provide structural information before and after allostery 
takes place, which is the basis for understanding the force field around the protein 
molecule. However, the dynamic information provided by crystallography is 
limited57. NMR, on the other hand, is able to provide atomistic details on biological 
macromolecules for timescale ranging from picoseconds to seconds58. Labeling 
two different moieties of a protein within a certain range with fluorescent resonance 
energy transfer (FRET) probes can monitor and calculate the distance in between 
different conformational states, therefore, tracking the conformational change57. 
Hydrogen Deuterium Exchange Mass Spectrometry (HDEMS) is another robust 
method for allosteric effects. Combined with structural information, HDEMS can 
map the protein-ligand interactions with high sensitivity59. Base on experimentally 
reported motion, force field, and flexibility of residues and protein structures, 
computational biology has become an increasingly helpful and reliable tool for 
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simulating enzyme dynamics and providing visualization of gaps in experimental 
data60. 
1.4.3 Importance and applications of enzyme allostery 
Understanding allostery mechanisms are important for understanding 
biological processes and drug discovery. Allosteric effects are numerous in the cell 
and include non-covalent mechanisms from ionic interactions, ligand binding, 
assembly of multi-molecule complexes, to light absorption, and covalent 
mechanisms such as post-translational regulation61. Hemoglobin is a well-known 
example of allosteric regulation by ligand binding. The switch between the R 
(relaxed) and T (tense) states of hemoglobin is triggered by pH changes and 
binding and release of the oxygen molecule62,63. The histidine residue (146ß) in 
hemoglobin is one of the modulators for the observed allosteric effect64. Allosteric 





Figure 4 Relative velocity of enzymes that obey Michaelis-Menten kinetics and enzymes that 
exhibit allosteric velocity. Adapted from Essentials of Biochemistry (For Medical Students) (p20), 
by B.S. Nayak, 2013, Jaypee Brothers Medical Publishers (P) Ltd. 
 
The distance between allosteric binding sites and substrate binding sites can 
vary66. Main types of allostery regulation include homotropic regulation and 
heterotropic regulation. If the effector is also the substrate of the enzyme, then it 
is called a homotropic allosteric effector, otherwise, it is a heterotropic allosteric 
effector67. The kinetics of allosteric enzyme catalytic rate does not follow Michaelis-
Menten curve68 but shows a sigmoidal increase of velocity with the increase of 





Figure 5. The rearrangement of chorismic acid to prephenic acid by chorismate mutase. 
Adapted from “Allosteric Regulation of Catalytic Activity: Escherichia coli Aspartate 
Transcarbamoylase versus Yeast Chorismate Mutase” by K. Helmstaedt, S. Krappmann, 
and G. H. Braus, 2001, Microbiology and Molecular Biology Reviews, 65 (3), p. 404-421. 
Copyright 2001 by the American Society for Microbiology.  
 
Chorismate mutase (CM) is a well-characterized and the smallest model of 
enzyme allosteric regulation  which is in its oligomerization state and can be either 
activated or inhibited by homotropic and heterotropic allosteric effectors, 
respectively69. CM rearranges chorismic acid to prephenic acid (Figure 6). In 
prokaryotes, CM is fused to prephenate dehydratase (P-protein) which yields 
phenylalanine, to prephenate dehydrogenase (T-protein) to yield tyrosine, or to 
phosphate synthase70. While in eukaryotes, the reported CM are found to be 
monofunctional69. Interestingly, the structural and functional set up of 
PRODH/P5CDH is similar to that of CM, with PRODH and P5CDH fused together 
as a bifunctional enzyme in prokaryotes and as separate enzymes in eukaryotes.  
Formylglycinamideribonucleotide amidotransferase (PurL) is another good 
allosteric enzyme example. The bifunctional PurL is recently discovered to be able 
to form a transient tunnel between the two active sites to transfer the intermediate71. 
In PurL, the at loop at the N-terminal domain adopts defined secondary structure 
upon the binding of substrate and acts as a cap covering one of the active sites, 
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the formylglycinamidine synthetase site71. Such conformational change could also 
be possible upon the binding of proline to PutA which would facilitate the catalytic 
activity of either one or both active sites. 
The fact that allostery is so prevalent in the cell suggests the study and 
discovery of allosteric modulators will bring great potential for clinical application. 
The famous inhibitor of rapamycin is an allosteric inhibitor for both mammalian 
targets of rapamycin (mTOR) and the proteasome72. The first allosteric drug 
approved by FDA was in 2004, and allosteric modulation has become an emerging 
strategy for therapeutic development and drug discovery57,73. An allosteric drug for 
the most recent pandemic caused by coronavirus 19 has been proposed and is 
currently under clinical trial studies74,75. 
1.4.4. Allostery in PutA 
 
Figure 6. RHH (ribbon-helix-helix structure) is a typical DNA binding protein 
domain. L1 (linker 1) is connecting the RHH and PRODH domain in wild-type 
EcPutA. CTD (C-terminal domain) has critical role in membrane association. The 
Δ50-85 EcPutA mutant lacks L1.  
 
One focus of my thesis project is to explore the role of the linker region in the 
functional switching mechanism of EcPutA (Chapter 2). The linker region includes 
residues 50-85 and connects the DNA and PRODH domains of EcPutA (Figure 6). 
The function of the linker region is unknown but previously it was postulated to be 
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critical for the functional switching mechanism of EcPutA76. It may be that the linker 
region is important for communicating redox signals from the PRODH domain to 
the DNA binding domain.  
Allostery in EcPutA involves communication from the FAD binding site to the 
membrane-binding domain77. The membrane-binding domain involves the α–
domain near the PRODH active site and C-terminal residues 1309-132077. 
Although far apart in sequence, these regions of EcPutA are postulated to form a 
membrane-binding surface in the three-dimensional structure of the enzyme77. 
Reduction of the FAD cofactor initiates allosteric effects that are relayed out from 
the FAD through the PRODH domain resulting in activation of membrane binding. 
The communication pathway is not known, however, a residue on a loop in the 
active site have been shown to be critical for redox communication78,79. These 
include residues Asp370, Glu372, and Glu373 of EcPutA PRODH domain which 
are highly conserved in PRODHs (see Figure 3)79. Mutation of these residues 
abrogates proline induced functional switching of EcPutA79. 
Linker regions between functional domains in enzymes can have a critical role 
in enabling protein dynamics that are necessary for function80–82. In a previous 
study the DNA binding domain of EcPutA (RHH) was fused to the N-terminus of a 
type 2 bifunctional PutA (RcPutA from Rhodobacter capsulatus) without a linker76. 
The resulting EcRHH-RcPutA chimera exhibited DNA binding, PRODH and 
P5CDH activities and lipid binding was induced by proline76. Whether the EcRHH-
RcPutA chimera could regulate the put regulon in cells was not examined. A major 
focus of my thesis project is to examine the impact of deleting the linker segment 
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in EcPutA to determine the functional role of the linker in redox allostery and 
functional switching. This work is described in Chapter 2. 
1.5 Enzyme promiscuity 
Enzymes are well known for their substrate specificity. Counter-intuitively, it is 
not uncommon to see enzymes catalyzing more than one reaction. Such a 
phenomenon is called enzyme promiscuity. Contribution to enzyme promiscuity 
includes evolution, hydrophobic interactions, the reactive potential of active sites, 
post-translational modifications, reaction condition, (e.g. pH, temperature, and 
media), diverse enzyme conformations, alternative cofactors or residues, 
structural similarity of the substrates, side reaction of the catalysis, and accidental 
mutations83–85. From the evolutionary perspective, the organism benefits from 
promiscuous enzymes86. In general, the side reaction of the promiscuous enzymes 
is generally a few magnitudes lower than their main reaction87. However, over the 
course of evolution, under the selection pressure, the side reaction of some of 
those enzymes evolved to be their main reaction84. Understanding the mechanism 
of enzyme promiscuity will expand our knowledge on cell signaling pathways and 
have great potential in the biotechnology field especially for protein engineering88.  
 Enzymes distinguish their substrates by the substrate properties, therefore, 
studying the kinetics of substrate analogs can identify new substrates or inhibitors. 
Moreover, the screening of natural analogues may lead to the discovery of new 
cellular functions of an enzyme.   
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1.6 Natural proline analogues and potential applications 
As previously described, proline is involved in several cellular functions and is 
a protein-building amino acid. Proline also plays a critical role in proteins by 
disrupting α–helix secondary structure otherwise known as an α–helix breaker. 
Besides understanding the numerous biological roles of proline, there is also 
significant research on natural occurring analogs of proline found in various 
organisms such as bacteria, fungi, protozoans, plants, and humans. Some of the 
proline analogs are precursors of antibiotics  and mycotoxins89. A review paper by 
Dr. Anthony Mauger (1996) summarized the source, stereochemistry, and function 
of most known 5-member ring natural proline analogs with carbon-, nitrogen-, 
oxygen-, and chlorine- substitutions known at that time89. Some typical proline-
analogs include trans- and cis- 4-hydroxyl-L-proline, trans and cis- 3-hydroxy-L-
proline, α-methyl- and α-benzyl-L-proline, and L-azetidine-2-cartboxylic acid90.  
 
Figure 7. Structures of three proline analogues of thiazolidine-2-carboxylic acid (T2C), 
thiazolidine-4-carboxylic acid (T4C) and 1,3-dithiolane-2-carboxylic acid (D2C). 
Recently, 1,3-dithiolane-2-carboxylic acid (D2C) (Figure 7) was found to be 
photoactivated and reduce the bound flavin. For this thesis project we were 
particularly interested in sulfur-containing natural proline analogs, namely L-
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thiazolidine-2-carboxylate (T2C) and L-thiazolidine-4-carboxylate (T4C) (Figure 7). 
T2C is formed by the reaction of glyoxylate and cysteamine91. Thiazolidine-4-
carboxylic acid (T4C or thioproline) is the condensation product of L-cysteine and 
formaldehyde.  Both T2C and T4C are naturally occurring sulfur-containing proline 
analogs with biological functions in a wide range of organisms (Figure 7). Under 
minimal nutrient conditions, T2C and T4C supplementation showed partial or full 
reversion of the growth profile of Colletotrichum trifolii92. T4C can serve as a 
nutrient93–95 and antioxidant96 and scavenge free radicals, especially nitric 
oxide97,98. In plants, T4C treatment showed improved seedling growth99 and 
increased drought tolerance in peanut cultivars100.  
T4C also possesses different therapeutic benefits in humans. For example, T4C 
has been used to treat liver disease for several decades97; it can inhibit human 
cancer cell growth101–103, reverse the transformation of advanced cancer104, and 
prevent the development of aging-related disease atrial fibrillation105. An important 
biological role of T4C appears to be as a storage molecule for L-cysteine, with L-
cysteine being generated through the oxidative metabolism of L-T4C106. 
Derivatives of L-T4C have also been shown to be involved in a variety of cellular 
functions including working as a cytoprotective agent, biosynthesis of a copper 
complex107, and inhibiting tyrosinase108. Despite many positive attributes, L-T4C is 
also known for being toxic to cells. The main toxicity mechanism of L-T4C is 
inhibition of protein synthesis by competitively binding to prolyl-tRNA synthetase 
and being mis-incorporated into proteins109,110. Recently, a proline peptidase was 
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shown to reverse L-T4C toxicity in E. coli by cleaving the thioproline incorporated 
into proteins and releasing T4C to be then degraded via oxidative metabolism, 
presumably by PutA111.  
Previously, D-T2C was shown to be a substrate for the flavoenzyme D-amino 
acid oxidase91. Recently, L-T2C was reported to covalently modify the flavin 
cofactor of SmPutA112, renewing interest in this proline analog as a potential lead 
compound for inhibition of PRODH in cancer cells. A focus of thesis project was to 
examine proline catabolic enzymes in the metabolism of L-T2C and L-T4C. 
Despite the important biological effects of these compounds and their therapeutic 
potential, enzymological characterization of thioproline metabolism by proline 
catabolic enzymes has not been reported. In this thesis SmPutA was used as a 
model for exploring oxidative metabolism of thioproline by proline catabolic 
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Chapter 2 The linker region is an allosteric regulator of proline utilization A 
in Escherichia coli 
Note: Most of the data reported here will be used to prepare for a manuscript. Lu 
Zhang has contributed to the cell-based assays, and Benjamin W. Arentson has 
prepared the pET21a-∆50-85 EcPutA and pUC18-∆50-85 EcPutA plasmids. 
 
Abstract 
The amino acid proline plays a number of roles in cellular functions; thus, the 
proper regulation of its metabolism is critical. In Gram-negative bacteria, proline is 
catabolized to glutamate by proline utilization A (PutA), a bifunctional enzyme 
containing proline dehydrogenase (PRODH) and L-glutamate-γ-semialdehyde 
dehydrogenase (GSALDH) domains. Some PutAs also contain a DNA binding 
domain and are known as trifunctional PutAs, not only catalyzing proline 
metabolism but also regulating the expression of the putA gene and the putP gene 
encoding the proline transporter, PutP. A linker sequence between the DNA 
binding domain and PRODH domain is shared in all trifunctional PutAs. In this 
study, we explored the functional role of the linker in the trifunctional PutA from 
Escherichia coli (EcPutA). An EcPutA variant lacking the linker (∆50-85 EcPutA) 
was generated and characterized by steady-state kinetics, DNA-binding assays, 
and cell-based activity assays. The oligomerization state, DNA binding ability and 
PRODH activity of ∆50-85 EcPutA was similar to that of wild-type EcPutA. Cell-
based assays showed ∆50-85 EcPutA was able to couple proline oxidation with 
reduction of the cytoplasmic membrane and regulate a put reporter gene in 
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response to proline. Unexpectedly, the GSALDH domain, which is far away from 
the linker, displayed significantly lower activity both in vitro and in vivo. Altogether, 




Proline has multifaceted roles in cellular metabolism, including critical roles in 
cellular bioenergetics1–4, redox homeostasis5, stress response6, osmoprotection6–
8, and bacterial pathogenesis9–12. The first step of proline catabolism is via proline 
dehydrogenases (PRODH), which oxidizes proline to Δ1-pyrroline-5-carboxylate 
(P5C)13. The P5C is non-enzymatically hydrolyzed to L-γ-glutamic semialdehyde 
(GSAL), which can be further oxidized to L-glutamate by L-glutamate-γ-
semialdehyde dehydrogenase (GSALDH)13. In certain species, the PRODH is 
transcribed together with GSALDH and the fused polypeptides are known as 
proline utilization A (PutA)13 (see Figure 1).  
An additional DNA binding domain is found at the N-terminus of PutAs from 
some gram-negative bacteria, such as Escherichia coli, Pseudomonas putida, 
Klebsiella aerogenes and Salmonella typhimurium14 (Figure 1). The DNA binding 
domain from E. coli PutA (EcPutA) contains a typical ribbon-helix-helix domain 
(RHH), the binding of which to the put regulon (putC) represses the expression of 
putA and putP, the latter encodes the high-affinity Na+/proline transporter15,16. The 
redox state of the PutA flavin cofactor controls whether PutA functions as an 
enzyme or as a DNA-binding transcriptional regulator, a phenomenon known as 
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functional switching17–19. When proline is absent, the bound flavin remains in the 
oxidized state and PutA binds to putC; in the presence of proline, proline reduces 
the flavin causing a global conformational change of the PutA, which induces PutA 
binding to the cytoplasmic membrane. Once bound to the membrane, PutA 
catalyzes the oxidation of proline by transferring electrons from reduced flavin to 
ubiquinone in the electron transport chain20–23.  
Multi-domain proteins are common among all species highlighting the many 
physiological benefits of multiple functions in a single polypeptide24–26. Linkers, 
generally 2 to 31 amino acids long, are a common structural feature in multi-
domain proteins and provide necessary flexibility, rigidity, and communication for 
proper protein activities, especially for multi-domain proteins24,25. The DNA binding 
and PRODH domains of the EcPutA are connected by a 35-amino acid linker 
called L1. The structure and function of L1 is still unknown. Previous work has 
characterized the function and structure of the RHH and PRODH domains, 
however, a structure of full-length EcPutA that includes L1 has not yet been 
solved1,27. To understand the functional role of the L1 linker, we created the linker 
truncated EcPutA mutant, ∆50-85EcPutA, and characterized its enzymatic and 
DNA-binding properties. 
To characterize the functional role of the L1 region, we determined and 
compared the kinetic parameters of ∆50-85 and WT EcPutA. We show here that 
the ∆50-85 EcPutA has comparable DNA binding activity to that of WT EcPutA in 
vivo and in vitro. The ∆50-85 EcPutA PRODH kinetics using different electron 
acceptors are also similar to that of WT EcPutA. However, GSALDH activity is 5-
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fold lower and exhibits poor NADH production in cell-based assays relative to WT 
EcPutA.   These results are unexpected because the GSALDH catalytic domain is 




Figure 1. RHH (ribbon-helix-helix structure) is a typical DNA binding protein 
domain. L1 (linker 1) is connecting the RHH and PRODH domain in wild-type 
EcPutA. CTD (C-terminal domain) has critical role in membrane association. The 
Δ50-85 EcPutA mutant lacks L1.  
 
Material and Methods 
All chemicals and reagents were purchased from Fisher Scientific, VWR, or 
Sigma-Aldrich, unless otherwise specified. D,L-P5C was synthesized according to 
the method of Williams and Frank and stored in 1 M HCl at 4 ˚C28 and its 
concentrations were determined by measuring the formation of P5C and o-
aminobenzaldehyde (o-AB) complex at 443 nm (ε443 nm = 2590 M-1 cm-1) 28. JT31 
strain (F-, lacZ1125, λ-, putA1::Tn5, trpA49(Am), relA1, rpsL150(strR), spoT1) 
was a generous gift from J. Wood (University of Guelph, Guelph, ON). Membrane 
vesicles were prepared as previously described29. The putC DNA region with a 
fluorescent tag was amplified and purified as previously described21.  
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Cloning of ∆50-85 EcPutA 
The L1 linker was removed from EcPutA (EcPutA∆50-85) using the full-length 
pET21a-EcPutA construct. First, PCR site-directed mutagenesis was used to 
insert an EcoRI site at the codon for Asp48 in the pET21a-EcoRI construct using 
primers: 
(Fwd) 5’-CGAACAACTGGAAAACAGCGAATTCCTGCCGGAGC-3’  
(Rev) 5’-GCTGTTTTCCAGTTGTTCGAGATAAGAAAAAATCGC-3’.  
Next, a PCR product was generated with an EcoRI restriction site at the codon for 
EcPutA Asp84 (EcoRI-Asp84) from the full-length pET21a-EcPutA construct using 
primers: 
(Fwd) 5’-CCATTCCTCGACTTTGCCGAGGAATTCTTGCCCCAGTCG-3’  
(Rev) 5’-CGGCGCCTCGAGTTAACCTATAGTCATTAAGC-3’.  
The pET21a-EcPutA (EcoRI-Asp48) construct was then cut with EcoRI and XhoI. 
Following digestion, the pET21a vector coding for EcPutA residues 1-48 (EcPutA1-
48) was gel purified. Next, the EcPutA (EcoRI-Asp84) PCR product was digested 
with EcoRI and XhoI and ligated into pET21a-EcPutA1-48 using EcoRI and XhoI. 
The EcoRI site in the resulting construct was removed with the following primers: 
(Fwd) 5’-CGAACAACTGGAAAACAGCGACACCTTGCCCCAGTCGG-3’  
(Rev) 5’-GCTGTTTTCCAGTTGTTCGAGATAAGAAAAAATCGC-3’ 
to make a seamless pET21a-EcPutA∆50-85 construct. The pET21a-EcPutA∆50-
85 construct was confirmed by sequencing the entire gene. The EcPutA ∆50-85 
gene was then restriction cloned into pET15b using NdeI and BamHI and into 
pUC19 using BamHI and XbaI (see appendix for plasmid map and sequence 
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information) The pET15b-EcPutA∆50-85 construct was used for protein 
purification and the pUC19-EcPutA∆50-85 construct was used for cell-based 
experiments.  
Overexpression and purification 
WT EcPutA and ∆50-85 EcPutA were overexpressed in E. coli BL21(DE3) and 
C43 strains using pET14b-WTEcPutA and pET15b-EcPutA∆50-85 expression 
constructs, respectively. The WT EcPutA and ∆50-85 mutant were purified 
similarly as previously described with minor modifications18.  The cells were grown 
in TB media and induced at OD600 around 0.8 with 0.5 mM IPTG at 18 °C for 16 
hours. Cells were harvested and resuspended in 10 mL of Tris buffer (20 mM Tris, 
500 mM NaCl, 10% glycerol, pH 7.6 at 4˚C) with 5 mM imidazole (IMD) per gram 
of wet cell mass. Prior to cell lysis, TritonX-100 (0.2% final concentration), five 
protease inhibitors (3 mM ε-Amino-N-Caproic Acid, 0.3 mM phenyl methyl sulfonyl 
fluoride, 1.2 μM leupeptin hemisulfate, 48 μM N-tosyl-L-phenyl amine chloromethyl 
ketone, 78 μM N-α-p-tosyl-L-Lysine chloromethyl ketone; final concentrations), 
and 20 µM FAD (final concentration) were added to the cell suspension.  
All subsequent purification steps were carried out on ice or at 4˚C. The 
resuspended cells were lysed by sonication using a model 550 Sonic 
Dismembrator (Fisher Scientific) using a amplitude setting of 5, for 5 min total 
(pulse sequence of 5 s on and 15 s off). The cell lysate was centrifuged at 20,000 
g using a JA 20 rotor for 30 min. The supernatant was collected, filtered through a 
0.22 µm filter (Celltreat) before loading onto a Ni-NTA column. HisPur Ni-NTA 
Superflow Agarose (Thermo Fisher Scientific) was packed in a borosilicate glass 
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column pre-equilibrated using Tris buffer with 5 mM IMD. The flow-through was 
collected and loaded back onto the column again to maximize protein binding and 
purification yield. The column was then washed with 5 mM IMD followed by 
stepwise elution with Tris buffer containing 20, 40, and 250 mM IMD for WT EcPutA; 
or 10, 40, and 250 mM IMD for ∆50-85 EcPutA. Elution fractions (2 mL) were 
collected and analyzed by SDS-PAGE. Fractions with good yield and purity were 
pooled and dialyzed into Tris buffer (20 mM Tris, 150 mM NaCl, 10% glycerol, 0.5 
mM Tris(hydroxypropyl)phosphine (THPP), pH 7.6). The dialyzed protein was then 
concentrated using an Amicon stir cell with 100-kDa molecular weight cut off 
ultrafiltration disc (MilliporeSigma). Protein concentration was determined by the 
Pierce assay and by UV-visible absorbance of the protein-bound flavin using the 
extinction coefficient of 12700 mM-1cm-1 at 450 nm30. The N-terminal His-tag was 
retained in the purified WT EcPutA and ∆50-85 EcPutA proteins. 
Cell-based assay 
JT31 lacZ- cells containing the pACYC-putC:lacZ reporter construct (low copy) 
was used to test the transcriptional repressor activity of WT EcPutA and ∆50-85 
EcPutA using the β-galactosidase activity assay as previously described15. In brief, 
JT31 lacZ- (putC:lacZ) cells were transformed with pUC18-EcPutAWT, pUC19-
EcPutA∆50-85, and pUC18 empty vector. The cells were grown in M9 minimal 
media (standard M9 media supplemented with 10 µM FeSO4, 0.005% L-tryptophan, 
and 0.05% thiamine with antibiotics 50 µg/mL ampicillin, 34 µg/mL 
chloramphenicol, 25 µg/mL kanamycin) with or without 15 mM proline and were 
induced at OD600 0.2 with 0.25 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). 
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Cells were harvest at OD600 around 0.8 and then lysed to measure β-galactosidase 
activity. β-galactosidase activity assays with the cell lysates were conducted as 
previously described31.  β-galactosidase activity is reported in Miller Units, which 
was calculated using equation 1, where t is the time (min) and v is the volume of 
cells used (mL). 
Miller Unit = 1000∗(Abs420−(1.75∗Abs550))/(t∗v∗Abs600) (1) 
Gel mobility shift assay 
The DNA-binding activity of ∆50-85 EcPutA was characterized using in vitro gel 
shift assays performed similarly as previously described32. ∆50-85 EcPutA (0 – 4 
µM) was incubated with 2 nM putC DNA (420 bp) containing a fluorescent tag 
(IRdye-700 labeled at the 5’ end) and 200 µg/mL calf thymus DNA as a nonspecific 
DNA control in 50 mM Tris-HCl, 10% glycerol, pH 7.5 for 20 min at room 
temperature. The binding assay mixtures were loaded onto 4% native 
polyacrylamide gel, which was run at a constant voltage of XX for X min at 4 ˚C to 
separate the free and protein-bound DNA. The percentage of bound DNA was 
quantified with ImageJ software and the binding constant was determined using 
equation 2 where n is the number of binding sites (n=1 was fixed when fitting the 
data) and [P] is total protein concentration. 
Fraction of DNA bound = n[P]/(KD + [P])  (2) 
Oligomerization determination 
Sedimentation velocity experiments were conducted at 20 ˚C using a Beckman 
XL-I analytical ultracentrifuge and An50Ti rotor as previously described33. ∆50-85 
EcPutA (5 mg/mL) with or without 15 mM proline in Tris buffer (20 mM Tris, 150 
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mM NaCl, pH 7.5) was loaded in a sedimentation velocity cell. Data was analyzed 
using Sedfit34. 
Steady-state PRODH and GSALDH kinetics 
PRODH activity was determined by using DCPIP (2,6-
Dichlorophenolindophenol) or CoQ1 (ε278 = 14.3 mM-1cm-1)35 as the electron 
acceptor23,36,37. In brief, 0.1 µM enzyme was mixed with 75 µM DCPIP, 0.3 mM 
phenazine methosulfate (PMS), and proline (0-600 mM) in 20 mM Tris-HCl, 10% 
glycerol, pH 7.5 for the DCPIP assay. When using CoQ1 as the electron acceptor, 
0.2 µM enzyme was mixed with 4 mM o-aminobenzaldehyde (o-AB) in 50 mM 
potassium phosphate buffer (pH 7.5, 150 mM NaCl). In assays in which CoQ1 was 
varied (0 – 250 µM), proline concentration was fixed at 40 mM.  In assays varying 
proline (0-200 mM) CoQ1 concentration was fixed at 0.2 mM. KM and kcat values 
were obtained by fitting the initial rates to Michaelis-Menten equation using Prism38.  
 GSALDH assays were performed as previously described39. D,L-P5C stocks 
were neutralized with 1 M Tris-HCL (pH 9.0) on the day of the assays. EcPutA 
enzyme (2 µM) was mixed with 0.2 mM NAD+ and varied L-P5C (0 – 3000 µM) in 
50 mM phosphate buffer (pH 7.5, 150 mM NaCl). Activity was monitored by 
tracking the formation of NADH at 340 nm (ε340 = 6.22 mM-1cm-1 40). All kinetic data 
plots and parameters are reported using L-P5C concentration, which is considered 
to be half of D,L-P5C. 
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Steady-state PRODH-GSALDH coupled activity assay 
The PRODH-GSALDH coupled activity of EcPutA with L-proline was assayed 
as previously described41. The reactions contained 0.25 µM WT EcPutA or ∆50-
85 EcPutA, 0.2 mM CoQ1, 0.2 mM NAD+, and 20 mM of L-proline in the assay 
buffer (50 mM potassium phosphate, 25 mM NaCl, pH 7.5). The coupled activity 
was measured by monitoring NADH production at 340 nm (ε340 =6.22 mM-1 cm-1). 
Cell-based functional assays 
To study functional membrane association in vitro, membrane vesicles were 
used as electron acceptor as previously reported42–44. EcPutA enzyme (0.2 µM) 
was mixed with 0.05 mg total protein/mL of membrane vesicles, 4 mM o-AB and 
varied proline (0 – 250 mM) in 20 mM MOPS (pH 7.5, 10 mM MgCl2). The rate of 
P5C-oAB complex formation was followed at 443 nm (2,590 m−1·cm−1 at 443 nm)45 
and used to determine the initial velocity of the reaction.  
Membrane association in vivo was tested as previously described by growing 
cells harboring WT or ∆50-85 EcPutA on M9 minimal media agar plates with 2,3,5-
Triphenyl tetrazolium chloride (TTC), a indicator dye for reduction of the respiratory 
chain in the cytoplasmic membrane 42. BL21 (DE3) putA- cells were transformed 
with pET21a-WT EcPutA, pET21a-EcPutA ∆50-85, or pET21a empty vector. Cells 
were cultured in LB broth (37 oC) until reaching OD600 of 0.5 and then streaked 
onto M9 minimal plates containing 0.25% TTC, 0.5% glycerol or proline (weight to 




To monitor the kinetics of FAD reduction and NADH formation in whole cells, 
BL21 (DE3) putA- cells containing pET21a-WT EcPutA or pET21a-EcPutA ∆50-85 
were grown in LB broth to OD600 of 0.6 and induced with 0.5 mM IPTG for 3 h at 
37 ˚C. The cells from 50 mL culture were then spun down and resuspended in 50 
mM potassium phosphate (pH 7.5, 150 mM NaCl) to a final OD600 of 20. The 
resuspended cells were then placed in a 5 mL Desa suspension presentation 
chamber and placed in the OLIS CLARiTY. Proline (15 mM final concentration) 
was then added to the cell mixture with continuous stirring and UV-visible 
wavelength scans from 300 to 600 nm were collected at 1 min intervals for up to 
20 min in the OLIS CLARiTY spectrophotomer. The absorbance changes at 450 
nm and 340 nm represent FAD reduction and NADH formation, respectively. 
Redox potential of ∆50-85 EcPutA 
The redox potential of ∆50-85 EcPutA was determined using the 
xanthine/xanthine oxidase method as previously described for WT EcPutA46. In 
brief, 15 µM ∆50-85 EcPutA was mixed with 100 µM xanthine, 100 µM benzyl 
viologen (mediator dye), and 100 µM resorufin (-79 mV, indicator dye) in potassium 
phosphate buffer (10 % glycerol, 50 mM potassium phosphate, 150 mM NaCl, pH 
7.5). The enzyme-dye solution was then degassed with 12 nitrogen-vacuum cycle 
and transferred to an anaerobic chamber (Bell Technology Glovebox). Xanthine 
oxidase (5 nM) was then added to initiate reduction of ∆50-85 EcPutA, which is 
recorded using a Cary 100 UV-Vis spectrophotometer at 1 min intervals for up to 
5 h. The ratio of (oxidized/reduced) dye and (oxidized/reduced) flavoprotein was 
determined at different time points by following the absorbance at 570 nm and 450 
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nm, respectively. The redox potential of ∆50-85 EcPutA was then determined by 
fitting both protein and dye to equation 3 assuming the reaction reaches 
equilibrium over the slow reducing procedure. 






NAD+ binding study 
NAD+ binding to WT EcPutA and ∆50-85 EcPutA was studied by monitoring 
the intrinsic tryptophan fluorescence in the presence of NAD+ as reported 
previously41. 0.25 µM WT or ∆50-85 EcPutA was mixed with varied 
concentrations of NAD+ (0-120 µM) in 10 mM potassium phosphate (pH 7.5). 
Maximum excitation and emission wavelengths of NAD+ were determined to be 
290 nm and 335 nm. Therefore, the mixture was excited at 290 nm and emission 
at 335 nm was recorded. The fluorescent signal was corrected using equation 4 
and the KD was determined using equations 5 and 6. 
F4/&& =	F/5$ 	× 	10(7!"87!#)/'   (4) 
 
θ = 	 -[<7=
$]%&!!
?'8	[<7=$]%&!!
  (5) 
 
[NAD8]@&"" =	 [NAD8]A/A#B −	θ[EcPutA]A/A#B  (6) 
 
Thermal shift assay and melting point temperature study 
For thermal shift assays, WT or ∆50-85 EcPutA (2.5 µM) was mixed with 1 x 
SYPRO orange dye (Bio-Rad), with or without 20 µM NAD+ in 25 µL PBS buffer 
(pH = 7.4), which is known for its stable pH at different temperatures. The thermal 
shift assays were performed using a Bio-Rad CFX Connect Real-Time PCR 
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detection system, with a temperature range of 10-95 oC with 0.5 oC intervals, and 
10 sec at each temperature. The Tm was calculated from Beamer Lab software47. 
The stability of the WT and ∆50-85 EcPutA was also studied using circular 
dichroism. The CD spectra of WT and ∆50-85 EcPutA (0.4 µM) in 10 mM 
potassium phosphate with or without 4 µM NAD+ were monitored from 5 to 95 oC 
with 5 oC intervals. The melting temperature was obtained by fitting the change of 
absorbance at 222 nm versus temperature to a sigmoidal curve. 
Statistical analysis 
All assays were performed in technical triplicates, unless otherwise stated, and 




General properties  
The L1 linker-truncated mutant (Δ50-85 EcPutA) (Figure 1) has a predicted 
molecular weight of 143.55 kDa and purifies as a soluble protein. Purified ∆50-85 
EcPutA has maxima absorbance peaks at 380 nm and 451 nm, similar to that of 
WT EcPutA. The percent flavin bound was estimated to be ~50% for ∆50-85 
EcPutA based on protein quantitation using the Pierce assay and the UV-visible 
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spectrum of bound FAD (Figure 2). WT EcPutA typically purifies with 80-90% 
bound FAD. 
Oligomeric state and DNA binding 
The RHH DNA-binding domain is responsible for the dimeric structure of WT 
EcPutA. Here we determined the oligomeric structure of ∆50-85 EcPutA by 
sedimentation velocity. Figure 3 shows ∆50-85 EcPutA exhibited a sedimentation 
coefficient of ~ 9 which corresponds to a molecular weight of 309 kDa.  This result 
is within 10% of the predicted molecular weight of a dimer for ∆50-85 EcPutA (287 
kDa). Addition of proline did not change the oligomerization state as observed by 
sedimentation velocity (data not shown).  












Figure 2. Spectrum of purified ∆50-85 EcPutA. The spectrum shows a peak at 





Figure 3. Oligomerization state study of ∆50-85 EcPutA. (A) Size distribution plot 
and sedimentation constant for ∆50-85 EcPutA (5 mg/mL). (B) Representative 

































Figure 4. DNA binding assays of Δ50-85 EcPutA. (A) Gel-mobility shift assay of 
putC DNA with increasing concentration of Δ50-85 EcPutA. (B) A plot of the 
fraction of bound DNA vs Δ50-85 EcPutA concentration. 5’-labeled (IRdye-700 
label) putC region (419 bp) and varying concentrations of Δ50-85 EcPutA (0-1000 
nM) was incubated in separate binding mixtures (50 mM Tris, 10% glycerol, 20 nM 
IRdye-700, 200 μg/mL calf thymus DNA, pH 7.5) at room temperature for 20 
minutes. The complexes were separated using 6% polyacrylamide native gel at 
4 °C. The fraction bound are reported as the average from 10 replicates ± standard 
deviation. The data were fit to equation 1 to yield an overall dissociation constant 
of 187 ± 42 nM. (C) MST DNA binding assay using a fixed concentration of 5’- 
IRdye-700-putC DNA and increasing concentration of Δ50-85 EcPutA. 
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The DNA binding activity of EcPutA is dependent on the RHH domain, which 
must be a dimer to bind the DNA. The observation that ∆50-85 EcPutA purifies as 
a dimer indicates that the RHH domain is able to form a functional dimeric DNA 
binding domain. The DNA binding activity of ∆50-85 EcPutA was first tested by 
electrophoretic mobility shift assays (EMSA). Figure 4A shows that a protein-DNA 
complex was formed with increasing concentration of ∆50-85 EcPutA. A plot of the 
fraction of bound DNA vs ∆50-85 EcPutA concentration yielded a dissociation 
constant (KD) for the protein-DNA complex of 187 ± 42 nM (Figure 4B), which is 
four-fold higher compared to that of WT EcPutA (KD = 45 nM)48. To confirm the 
result from EMSA, we also tested DNA binding using microscale thermophoresis 
(MST). A serial 2-fold dilution of ∆50-85 EcPutA was mixed with a fixed 
concentration of fluorescently labeled putC DNA. The change of the fluorescence 
signal was recorded as function of ∆50-85 EcPutA concentration from which a KD 
of 247 nM was determined (see Figure 4C). Thus, two independent experiments 
confirmed that ∆50-85 EcPutA displays DNA binding activity.  
PRODH activity and flavin redox potential 
We next examined the PRODH kinetic activities since it is directly connected 
to the L1 region. We tested PRODH activity using L-proline and three different 
substrates as electron acceptors, DCPIP, CoQ1, and membrane vesicles. Proline 
was varied while each electron acceptor was held at a fixed concentration. The KM 




Figure 5A shows the plot of initial velocity vs proline concentration for assays 
using a fixed concentration of membrane vesicles. Overall, the kinetic parameters 
for PRODH activity of ∆50-85 EcPutA are similar to that of WT EcPutA (Table 1). 
The highest catalytic efficiency was observed using membrane vesicles as the 
electron acceptor. The ability of ∆50-85 EcPutA to couple proline oxidation to 
reduction of ubiquinone in the cytoplasmic membrane was confirmed by cell-based 
assays in which reduction of TTC was monitored. Figure 5B shows cells 
expressing WT EcPutA and ∆50-85 EcPutA both result in proline dependent 





Figure 5. Functional membrane activity assays. (A) Show the Michaelis-Menten 
plot of your PRODH activity with membrane vesicles for ∆50-85 EcputA. This 
would complement the cell-based data in panel B. (B) Cell-based functional 
assays. BL21(DE3) putA- E. coli strain was transformed with pUC18 empty 
vector, ∆50-85 EcputA-pUC18 or WT EcPutA-pUC18 gene. Cells were in LB 
media and streaked on M9 agar plates containing 0.25% TTC indicator and 
0.5% proline and grown overnight at 37 ̊ C. The red colonies (formazan) indicate 
the utilization of proline as a respiratory substrate and functional PutA-
membrane interactions.  
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The redox potential of the bound FAD is another indicator of the active site 
environment. To determine whether the L1 linker has any direct impact on the 
FAD binding site, the reduction potential of the FAD in ∆50-85 EcPutA was 
determined. Figure 6 shows the plot of log(ox/red) of protein-bound FAD versus 
log(ox/red) of resorufin. From this plot, a reduction potential of -111 mV for bound 
FAD was determined along with a slope of 0.9629, which indicates 2-electron 
transfer during reduction. The measured reduction potential of the FAD in ∆50-85 
EcPutA is near that of WT EcPutA (-106 mV) suggesting the proteins share 
similar FAD binding site environments. 
 
Figure 6. Redox potential of ∆50-85 EcPutA. The ∆50-85 EcPutA was mixed with 
10 µM resorufin (indicator dye), 100 µM benzyl viologen (mediator dye), and 150 
µM xanthine. The reduction of flavin is initiated by added 5 nM xanthine oxidase in 
50 mM potassium phosphate, 150 mM NaCl, pH 7.5 buffer. Everything is degassed 
and the reduction takes place in an anaerobic glove box. The spectrum has been 
monitored every minute for 5 hours. The spectrum of every 10 minute is reported. 
The intersect graph shows the log of intermediate dye and ∆50-85 EcPutA being 
reduced which show a slope of 0.9629.  





























Transcriptional regulation in vivo  
Because Δ50-85 EcPutA was shown to have similar DNA binding, PRODH 
activity, and functional membrane binding activity as shown above, we next sought 
to determine whether Δ50-85 EcPutA was capable of regulating put gene 
expression in response to proline. The ability of Δ50-85 EcPutA to function as 
proline-responsive transcriptional regulator was tested in cells using a β-
galactosidase assay. JT31 cells (lacZ-) transformed with pUC18 empty vector (EV), 
pUC18-∆50-85 EcPutA, and pUC18- WT EcPutA were grown on M9 media in the 
presence and absence of proline (15 mM). As expected, the negative control with 
pUC18-EV showed repression of the putC:lacZ reporter gene with and without 
proline (Figure 7). In contrast, both ∆50-85 EcPutA and WT EcPutA repressed lacZ 
gene expression in the absence of proline. In the presence of proline, a 3-6-fold 
increase in β-galactosidase activity was observed with ∆50-85 EcPutA and WT 
EcPutA.  
GSALDH activity and NAD+ utilization 
The last functional domain to examine is the P5CDH domain (Figure 1) which 
is spatially separated from the L1 region. Therefore, it seemed likely that ∆50-85 
EcPutA would show similar GSALDH activity relative to WT EcPutA. However, the 
kcat/KM for GSALDH activity by ∆50-85 EcPutA is only 350 M-1s-1 (Figure 8), which 





Figure 2. Cell-based assays of transcriptional regulation by ∆50-85 and WT 
EcPutA. β galactosidase activity in the JT31 lacZ- E. coli strain containing the 
putC:lacZ reporter construct and the pUC18 empty vector (EV), pUC18-∆50-85 
EcPutA or puC18-WT EcPutA. Cells were grown on M9 medium in the absence 
and presence of 15 mM proline. Miller units are reported as the average of four 
replicates ± standard deviation.   
 
Figure 3. P5CDH activity of ∆50-85 EcPutA. 1 µM ∆50-85 EcPutA was mixed with 
0.2 mM NAD+ and varied L-P5C (0-3000 µM) in potassium phosphate buffer (50 

































To investigate the cause of the decreased GSALDH activity of ∆50-85 EcPutA 
we examined NAD+ binding by intrinsic tryptophan fluorescence. Tryptophan 
fluorescence of ∆50-85 EcPutA and WT EcPutA was monitored while varying 
NAD+ concentration to determine the NAD+ binding constant (Figure 9). The KD of 
WT and ∆50-85 EcPutA are 0.59 ± 0.16 and 0.83 ± 0.27 µM, respectively, and the 
difference between the total fraction of PutA bound to NAD+ is not statistically 
significant. We next determined the GSALDH kinetic parameters of ∆50-85 EcPutA 
by holding P5C concentration fixed (3 mM) and varying NAD+. The kcat for ∆50-85 
EcPutA was 2-fold lower than WT EcPutA but the KM for NAD+ was observed to be 
similar to that of WT EcPutA (Table 2) further indicating no significant difference in 
NAD+ utilization. 
  
Figure 4. Tryptophan fluorescent quenching with NAD+. 0.25 µM ∆50-85 or WT 
EcPutA was mixed with 0-25 µM NAD+ excited at 290 nm and 335 nm emission 
was collected.  
Table 2. Kinetic constants for ∆50-85 EcPutA and WT EcPutA using varied NAD+ 
EcPutA 
Enzyme 
Activity Assay KM (µM) kcat(s-1) kcat/KM(M-1s-1) 
∆50-85 GSALDH 5.6 ± 1.8 0.82 ± 0.045 147000 ± 55000 
WTa 8.2 ± 3.5 1.564 ± 0.131 191000 ± 98000 
∆50-85 Coupled 0.016 ± 0.0054 0.20 ± 0.015 12000 ± 4800 
WTa 0.024 ± 0.003 0.73 ± 0.1 31000 ± 4000 
a Values were determined previously39. 

















PRODH-GSALDH coupled activity 
The ability of ∆50-85 EcPutA to couple the overall oxidation of L-proline to L-
glutamate was determined by mixing 0.1 µM with 20 mM proline, 0.2 mM CoQ1, 
and 0.2 mM NAD+ and monitoring the NADH production at 340 nm (figure 10).  The 
KM of NAD+ for the ∆50-85 EcPutA coupled activity is similar to WT EcPutA but the 
kcat is about 3-fold lower than that of WT EcPutA (Table 2). To test PRODH-
GSALDH coupled activity in vivo, we monitored the NADH production in living cells 
expressing ∆50-85 EcPutA and WT EcPutA using the OLIS CLARiTY. Proline was 
added to cells resuspended in phosphate buffer and the kinetics of FAD reduction 
and NADH formation were monitored for 20 min. Proline induced reduction of FAD 
and formation of NADH in cells with WT EcPutA (Figure 11A). In contrast, although 
proline induced FAD reduction in cells with ∆50-85 EcPutA, no significant formation 
of NADH was observed (Figure 11B). A plot of absorbance changes at 450 nm 
(Figure 11C) and 340 nm (Figure 11D) from an average of 6 independent 

















Figure 5. The comparison 
of ∆50-85 and WT EcPutA 
channeling activity. 0.1 µM 
enzyme was mixed with 0.2 
mM CoQ1, 0.2 mM NAD+, 
and 20 mM proline and 
absorbance 340 was 




     
 
Figure 6. PRODH-GSALDH coupled activity in whole cells. BL21(DE3) putA- was 
transformed with pET21a-∆50-85 EcPutA and pET21a-WT EcPutA expression 
constructs and grown in LB. Cells were induced with 0.5 mM IPTG at OD600 0.6 for 
3 h at 37 ˚C and resuspended in phosphate buffer (pH 7.5). PRODH-GSALDH 
coupled activity in live cells with WT EcPutA (A) and ∆50-85 EcPutA (B) was 
monitored by adding 15 mM proline and recording UV-visible spectra at 1 min 
intervals for up to 20 min. Shown is the plot of FAD reduction and NADH formation 
at 450 nm (C) and 340 nm (D) from 6 independent replicates.  
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Melting temperature study 
Since the ∆50-85 EcPutA shows lower GSALDH activity in vitro and in vivo, we 
examined the stability of ∆50-85 EcPutA compared to WT EcPutA. We performed 
thermal shift assays as well as a temperature dependent circular dichroism (CD) 
study to determine the melting temperature (Tm) of ∆50-85 EcPutA.  Because 
cofactors can sometimes stabilize proteins, we also tested the impact of NAD+ on 
the stability of ∆50-85 EcPutA. Figure 9A shows WT EcPutA has a higher Tm value 
than ∆50-85 EcPutA by 2 oC. In the presence of NAD+, the stability of WT EcPutA 
increased to a Tm value of 40.5 oC whereas NAD+ had no effect on the Tm of ∆50-
85 EcPutA. Thus, in the presence of NAD+, WT EcPutA shows a Tm that is 3 oC 
higher than that of ∆50-85 EcPutA. Analysis of temperature stability by CD showed 
similar Tm values for WT EcPutA and ∆50-85 EcPutA, however, in the presence of 
NAD+, WT EcPutA exhibited a slightly higher Tm (1 oC) than that of ∆50-85 EcPutA 





























































Figure 7. Melting temperature study of WT and ∆50-85 EcPutA. Tm values for WT 
and ∆50-85 EcPutA from thermal shift assays (A) and CD spectroscopy (B) in the 
absence and presence of 4 µM NAD+. (C), the melting temperature is obtained by 
fitting the data to a logarithm curve. C is the Plot of the change in absorbance at 
222 nm (A222) for WT and ∆50-85 EcPutA monitored by CD spectroscopy from 5 - 




Linker regions in multidomain proteins are typically flexible to enable functional 
coordination of different domains. In DNA-binding domains, the sequence of 
linkers can also be important for DNA recognition26. The L1 linker region in EcPutA 
was previously suggested to be highly flexible as it was identified by limited 
proteolysis to undergo a conformational change in the presence of proline at 
Ser5849. No structural information is currently available for the L1 region (50-85) 
due likely to high conformational flexibility50. EcPutA constructs with (EcPutA 1-90) 
and without (EcPutA 1-47) the L1 region were previously shown to exhibit DNA-
binding activity. However, EcPutA1-90 exhibited a 7-fold lower binding affinity (KD 
= 110 nM) to the putC DNA relative to EcPutA 1-47, (KD = 15 nM)21, which contains 
only the RHH DNA binding domain. The weaker DNA binding affinity of EcPutA1-
90 may be caused by the flexible L1 region interfering with DNA binding. In another 
previous study Arentson and coworkers fused the DNA binding domain of EcPutA 
to a type A bifunctional PutA from Rhodobacter capsulatus (RcPutA). The resulting 
chimeric EcRHH-RcPutA lacked the L1 region but still could bind to the putC 
intergenic DNA (KD = 58 nM) similarly to WT EcPutA21,23. Altogether, these results 
show that the L1 linker does not contribute to DNA recognition. 
Here, we conducted the first systematic study of the L1 linker in EcPutA.  Our 
results show that the L1 linker is not essential for EcPutA dimerization, DNA 
binding and transcriptional repressor activity. Although the DNA-binding affinity of 
∆50-85 EcPutA is 3-fold lower than WT EcPutA, ∆50-85 EcPutA is still able to 
function as a transcriptional repressor in vivo. Deletion of the L1 linker in ∆50-85 
54 
 
EcPutA had little impact on the FAD redox potential and PRODH activity and, did 
not disrupt functional membrane association. Cell-based assays confirmed the 
ability of ∆50-85 EcPutA to function as a proline-responsive transcriptional 
regulator despite lacking the L1 linker. Thus, it seems that the L1 is not necessary 
for EcPutA functional switching. The functional switching of trifunctional PutAs from 
DNA binding to membrane association is analogous to pyruvate oxidase in which 
flavin reduction triggers membrane binding, thereby enabling electron transfer to 
the electron transport chain in the membrane51. Pyruvate oxidase has linkers that 
interact with helices near the FAD binding domain that are released upon FAD 
reduction thereby enabling pyruvate oxidase to associate with the membrane.  
An unexpected finding from this study was the 5-fold decrease in GSALDH 
activity in ∆50-85 EcPutA relative to WT EcPutA. Interestingly, a previous N-
terminal truncation mutant of EcPutA (residues 86-1320) exhibited 2-fold lower 
GSALDH activity relative to WT EcPutA.52 Another indication of lower GSALDH 
activity in ∆50-85 EcPutA is the lack of NADH formation in whole cells upon adding 
proline. Addition of proline to the cells quickly reduces FAD but unlike WT EcPutA, 
no NADH production is observed. The apparent loss of GSALDH activity for ∆50-
85 EcPutA in vivo is not clear. NAD+ binding was shown to be similar between ∆50-
85 EcPutA and WT EcPutA. The melting curve studies using fluorescent dye 
thermoshift assays and CD both show WT EcPutA has a slightly higher Tm than 
∆50-85 EcPutA, which becomes more evident in the presence of NAD+. Thus, 
NAD+ binding appears to stabilize WT EcPutA but not ∆50-85 EcPutA. 
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Because the most significant impact of deleting the L1 linker is the loss of 
GSALDH activity in ∆50-85 EcPutA, it seems most plausible that the L1 linker 
contributes to the stabilization and function of the P5CDH domain. Studies that 
provide structural insights into how the L1 linker could influence the GSALDH 
domain will be the focus of future experiments. In addition, partially restoring the 
L1 linker sequence may generate novel information on which residues in the 50-








Figure S1. The plasmid map of pET15b. The ∆50-85 EcPutA gene was inserted in 





















































































S2. ∆50-85 EcPutA amino acid sequence with the first methionine highlighted. 
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Chapter 3.  Evidence for metabolism of thiazolidine carboxylates by proline 
catabolic enzymes 
This chapter is published: Mao, Y., Seravalli, J., Smith, T. G., Morton, M., 
Tanner, J. J., & Becker, D. F. (2021). Evidence for Proline Catabolic Enzymes in 




Thiazolidine carboxylates such as thiazolidine-4-carboxylate (T4C) and 
thiazolidine-2-carboxylate (T2C) are naturally occurring sulfur analogs of proline. 
These compounds have been observed to have both beneficial and toxic effects 
in cells. Given that proline dehydrogenase has been proposed to be a key enzyme 
in the oxidative metabolism of thioprolines, we characterized T4C and T2C as 
substrates of proline catabolic enzymes using proline utilization A (PutA), which is 
a bifunctional enzyme with proline dehydrogenase (PRODH) and L-glutamate-γ-
semialdehyde dehydrogenase (GSALDH) activities. PutA is shown here to 
catalyze the FAD-dependent PRODH oxidation of both T4C and T2C with catalytic 
efficiencies significantly higher than with proline. Stopped-flow experiments also 
demonstrate that L-T4C and L-T2C reduce PutA-bound FAD at rates faster than 
proline. Unlike proline, however, oxidation of T4C and T2C does not generate a 
substrate for NAD+-dependent GSALDH. Instead, PutA/PRODH oxidation of T4C 
leads to cysteine formation whereas oxidation of T2C generates an apparently 
stable Δ4-thiazoline-2-carboxylate species. Our results provide new insights into 
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INTRODUCTION 
 L-proline is unique among the natural amino acids due to the heterocyclic ring 
and secondary amine. Besides being essential for protein biosynthesis, L-proline 
has been shown to have critical roles in cellular bioenergetics, redox homeostasis, 
stress response, osmoprotection, and bacterial pathogenesis.1-5 Biological 
compounds rich in proline have also been shown to have promising antimicrobial 
therapeutic properties.6-9 One group of naturally occurring sulfur-containing proline 
analogs that are of important interest includes thiazolidine-4-carboxylate (T4C) 
and thiazolidine-2-carboxylate (T2C) (Scheme 1). T4C is a condensation product 
of L-cysteine and formaldehyde10, 11 whereas T2C is generated from glyoxylate 
and cysteamine.12 T4C has been reported to serve as a nutrient and cysteine 
source13, 14, act as an antioxidant4, 15 and scavenge free radicals such as 
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nitroxide.16, 17 Suggested therapeutic benefits of T4C include treatment of liver 
disease,16 inhibition of cancer cell growth and reversal of advanced cancer,18-21 
and prevention of aging related diseases.22, 23 T4C is also an important building 
block of ß-lactam antibiotics.24  
 
Scheme 1. Chemical structures of T2C and T4C. 
 Thioprolines have the potential to be toxic due to misincorporation into proteins 
or inhibition of protein synthesis.25-28 In Escherichia coli, it was recently discovered 
that the Xaa-Pro aminopeptidase, PepP, could rescue thioproline toxicity by 
removing thioproline misincorporated peptides.11 Intracellular toxic levels of T4C 
have been proposed to be diminished through oxidative metabolism via the 
enzymes proline dehydrogenase (PRODH) and Δ1-pyrroline-5-carboxylate 
reductase (PYCR).11, 29-31 PRODH was implicated first in L-T4C metabolism in 
assays using mitochondrial29 and E. coli membrane fractions.30 Later, E. coli PYCR 
was also reported to catalyze the oxidation of T4C via a NAD+-dependent 
reaction.31 D-T2C was shown previously to be a substrate for D-amino acid 
oxidase which converts D-T2C to Δ2-thiazoline-2-carboxylate.12 
 Although considered to have a prominent role in oxidative metabolism of 
thioprolines, to our knowledge the kinetic properties of a PRODH enzyme with T4C 
or T2C have not been determined.  PRODH is a FAD-dependent enzyme that 
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catalyzes the 2-electron oxidation of L-proline to Δ1-pyrroline-5-carboxylate (P5C, 
Scheme 2). This reaction is coupled to reduction of ubiquinone in the cytoplasmic 
membrane and in eukaryotes, the mitochondrial respiratory chain.1, 32-34 P5C 
subsequently undergoes hydrolysis to form L-glutamate-γ-semialdehyde (GSAL), 
which is then oxidized by the NAD+-dependent aldehyde dehydrogenase 
superfamily member GSALDH (a.k.a. ALDH4A1, P5CDH) to form L-glutamate 
(Scheme 2). The 4-electron oxidation of L-proline to L-glutamate by the 
consecutive reactions of PRODH and GSALDH is conserved among prokaryotes 
and eukaryotes.35, 36 In Gram-negative bacteria, PRODH and GSALDH are 
encoded in the same polypeptide chain, known as proline utilization A (PutA).35  
 To provide insights into the metabolic routes of T4C and T2C oxidation, we 
investigated the potential of PutA from Sinorhizobium meliloti (SmPutA) to use 
these compounds as substrates. SmPutA is well structurally characterized37 and 
recently, L-T2C was reported to covalently modify the flavin cofactor of SmPutA38; 
however, the modification occurred over a long incubation period (measured in 
days) and the kinetics of T2C oxidation were not characterized. Using SmPutA, we 
show here that both T4C and T2C are facile substrates with PRODH but that the 
oxidized products do not generate aldehyde substrates for GSALDH. We show 




that T4C is oxidized to Δ2-thiazoline-4-carboxylic acid (Δ2-T4C), which 
subsequently hydrolyzes to form cysteine, whereas T2C is oxidized to Δ4-
thiazoline-2-carboxylate (Δ4-T2C) and does not generate additional products. 
 
EXPERIMENTAL PROCEDURES 
Materials. All chemicals and buffers were purchased from Fisher Scientific and 
Sigma-Aldrich, unless otherwise noted. DL-P5C was synthesized according to the 
method of Williams and Frank and stored in 1 M HCl at 4 oC.39 P5C concentrations 
were determined by adding o-aminobenzaldehyde (o-AB) and measuring the 
absorbance at 443 nm (ε443 nm = 2590 M-1 cm-1).39 
Purification of SmPutA. SmPutA was expressed in Escherichia coli 
BL21(DE3) pLysS using the pNIC28 expression vector as previously described.37, 
38 A 5-mL overnight culture grown in LB was used to inoculate a 4 L-LB culture. 
Cells were grown at 37 ˚C until an OD600 of 0.6, at which point protein expression 
was induced with 0.25 mM IPTG for 10 h at 18 ˚C. Cells were harvested and then 
resuspended (1:10 ratio of wet cell mass to buffer volume) in 50 mM Tris buffer 
(pH 7.8) containing 300 mM NaCl, 5 mM imidazole, 5% glycerol, five protease 
inhibitors (3 mM ε-amino-N-caproic acid, 0.3 mM phenylmethylsulfonyl fluoride, 1.2 
µM leupeptin, 48 µM tosyl phenylalanyl chloromethyl ketone, and 78 µM tosyllysine 
chloromethyl 47 ketone hydrochloride), 20 µM FAD and 0.2% Triton-100. 
Resuspended cells were lysed on ice via sonication using a model 550 Sonic 
Dismembrator (Fisher Scientific) with a power setting of 5 for 5 min total using a 
pulse sequence of 5 s on and 15 s off. Cell lysed material was centrifuged at 20,000 
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g using a JA 20 rotor for 30 min and the supernatant was collected. The 
supernatant was passed through a 0.22 µm filter before loading onto a HisPur Ni-
NTA Superflow Agarose (Thermo Fisher Scientific) packed in a borosilicate glass 
column. The flow-through was loaded back onto the column again before washing 
and eluting with buffers resembling the binding buffer except with increasing 
imidazole concentrations (20 mM, 40 mM, and 300 mM). The eluted SmPutA was 
collected in 2 mL fractions, and SDS-PAGE under reducing conditions was used 
to determine the purity of the fractions. The selected fractions were pooled and 
dialyzed at 4˚C against dialysis buffer (50 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 
0.5 mM Tris(hydroxypropyl)phosphine, 10% glycerol, pH 7.8). The dialyzed protein 
was then concentrated via Amicon stirred cell using a 30 kDa molecular weight 
cut-off ultrafiltration disc from MilliporeSigma. The concentrated protein was flash-
frozen in 500 µL aliquots and stored at -80 oC. The N-terminal hexahistidine tag 
was retained in purified SmPutA. The concentration of PutA was determined using 
the BCA method (Pierce) and spectrophotometrically using a molar extinction 
coefficient of 12700 M-1 cm-1 at 451 nm.40 
 Steady-state PRODH Kinetics. The PRODH activity of SmPutA with different 
substrates was studied by monitoring the reduction of the electron acceptor 
Coenzyme Q1 (CoQ1) by absorbance at 278 nm (ε278 = 14.3 mM-1cm-1)41 using 1-
mL cuvettes and a Varian Cary 50 UV-visible spectrophotometer as previously 
described.42 The assay buffer contained 50 mM potassium phosphate and 25 mM 
NaCl at pH 7.5. All substrate stock solutions were made in sodium phosphate 
buffer (pH 7.5). The substrates and CoQ1 (final concentration of 0.2 mM) were 
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incubated in assay buffer for 5 min at room temperature before SmPutA (final 
enzyme concentration of 0.25 µM) was added to initiate the reaction. The substrate 
concentration was varied as follows: L-proline, 0 – 200 mM; L-T4C, 0 – 3 mM; and 
L-T2C, 0 – 2.5 mM. We note that T2C is commercially available only as a racemic 
mixture. All data are reported using the concentration of L-T2C, which was 
considered to be half of the DL-T2C concentration. The initial velocity (v0) was 
determined from the linear portion of the progress curve (0-5 min). Assays were 
performed in triplicate. Kinetic parameters were estimated by fitting initial rates to 
the Michaelis-Menten equation using SigmaPlot 12.0.43 Plotted is vo/[E] versus 
substrate concentration where V is the maximal reaction velocity of CoQ1 reduction 
and [E] is the concentration of SmPutA used in the assays (0.25 µM). 
 Steady-state PRODH-GSALDH Coupled Activity Assay. The PRODH-
GSALDH coupled activity of PutA with L-proline, L-T2C, and L-T4C was studied 
as previously described.44 The reactions contained 0.25 µM SmPutA, 0.2 mM 
CoQ1 as an electron acceptor, 0.2 mM NAD+, and L-proline (20 mM), L-T4C (5 mM) 
or L-T2C (5 mM) in the assay buffer (50 mM potassium phosphate, 25 mM NaCl, 
pH 7.5). The coupled activity was measured by monitoring NADH production at 
340 nm (ε340 =6.22 mM-1 cm-1). 
 Single-turnover PRODH Kinetics. All stopped-flow kinetic measurements 
were conducted with a Hi-Tech Scientific SF-61DX2 stopped-flow instrument 
equipped with a photodiode array detector at 23 oC as previously described.38, 44 
Enzyme, buffer, and substrate solutions were degassed using 12 cycles of vacuum 
and nitrogen. All substrate solutions were made in 50 mM phosphate buffer (25 
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mM NaCl, pH 7.5). In addition, 100 µM protocatechuic acid (PCA) and 0.05 U/mL 
protocatechuate 3,4-Dioxygenase (PCD) were included in the substrate solutions 
to scrub residual oxygen.45 SmPutA enzyme was rapidly mixed by stopped-flow 
with an equal volume of the following substrates at varied concentrations (all 
reported concentrations are after mixing):  L-T4C (0 – 100 mM), L-T2C (0 – 100 
mM), and L-proline (0 – 1000 mM). The reactions were monitored by 
multiwavelength absorption from 300-700 nm. The decrease in absorbance at 450 
nm was fit to equation 1 using SigmaPlot 12.0 to obtain the observed rate 
constants (kobs1 and kobs2) where Ao is the initial absorbance at 450 nm and A1 and 
A2 are the corresponding amplitudes. KD values were determined by plotting kobs1 
versus substrate concentration. The maximum observed rate constant (kmax) and 
the apparent KD were determined by fitting kobs1 to equation 2 as a function of 
substrate concentration ([S]). 
A(450) = A0 + A1*e(-kobs1*t) + A2*e(-kobs21*t)  (eq 1) 
kobs1 = (kmax*[S])/(KD + [S])   (eq 2) 
 To test PRODH-GSALDH coupled activity under single turnover conditions, 
SmPutA enzyme was rapidly mixed by stopped-flow with an equal volume of 
substrate solution containing 0.2 mM NAD+ and 20 mM L-T4C, L-T2C, and L-
proline. The reactions were monitored by multi-wavelength absorption from 300-
700 nm. 
Prediction of pKa Values. The pKa values of the nitrogen in proline, T2C, T4C, 
P5C, Δ2-T4C and Δ4-T2C were calculated using the structure-based chemical 
property prediction tool Chemicalize (https://chemicalize.com).46   
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Characterization of Products by Electrospray Ionization Mass 
Spectrometry. Electrospray ionization mass spectrometry (ESI-MS) was used to 
characterize the products generated during the reaction of SmPutA with L-T2C and 
L-T4C. The reaction mixtures contained after mixing (final concentration) 0.5 mM 
substrate (L-T4C or L-T2C) (pH 7.5) and 0.5 mM CoQ1 in 50 mM potassium 
phosphate buffer (50 mM NaCl, pH 7.5). The reactions were initiated by adding 
PutA (2 µM final concentration after mixing) except for the control sample (no 
enzyme).  The reaction mixtures were then incubated for 60 min at 23 °C followed 
by ESI-MS analysis. To test whether the reaction products also lead to cysteine 
formation, 1 mM iodoacetamide (final concentration after mixing) was added to 
each sample and the samples were incubated for an additional 10 min at 37 °C to 
allow for alkylation of thiol species, which yields stable carbamidomethylation 
(CAM) product compounds. 
Samples were then transferred into polyethylene V-vials and sealed with Al-
tops.  The samples were kept at 5 °C in the autosampler of the LC-1200 HPLC 
(Agilent, Santa Clara, CA) prior to column chromatography.  Samples were applied 
onto an Amide X-Bridge (2.1 mm x 150 mm, Waters, Milford, MA) column running 
at 350 µl/min at 25 °C with a gradient starting at 95% A (5% B) for 2 min, gradient 
to 55% A over 5 min, gradient to 5% A over 20 min, then 2 min hold at 5% A, 
followed by re-equilibration with 95% acetonitrile (A) for 10 min. The mobile phases 
consisted of acetonitrile (LC-Grade) (A) and 20 mM ammonium acetate in water 
(LC-Grade) supplemented with 20 mM ammonium hydroxide (B, pH 9.5).  The 
4000-QTrap mass spectrometer (Sciex, Framingham, MA) were set to operate in 
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single quadrupole, multiple reaction monitoring (MRM), and MS/MS modes.  The 
general electrospray conditions were:  electrospray ionization (ESI) potential = 
5000 V, temperature = 500 °C, ion source gas 1 = 60 L/min, ion source gas 2 = 80 
L/min, curtain gas = 20 L/min,  declustering potential = 60 V, collision entrance 
potential = 10 V, and collision exit potential = 15 V.  The collision energy values for 
the individual compounds were optimized by injections of authentic standards and 
were within the range of 15-30 V.  The data were collected and analyzed with 
Analyst version 1.6.1 and plotted using SigmaPlot 14.0.   
 Nuclear Magnetic Resonance (NMR) Analysis of T2C and T4C Reaction 
Products. NMR spectra were acquired on a Bruker Avance NEO 600 MHz NMR 
spectrometer equipped with a 5 mm TCI-H/F cryoprobe.  All spectra were acquired 
under dark lab conditions with overhead lights switched off.  Proton spectra were 
gathered before and after addition of the enzyme to the reaction mixtures. 
Deuterium oxide was added to the reaction mixture for spectrometer lock with L-
T2C, or for L-T4C, the reaction mixture was prepared primarily using deuterium 
oxide instead of water. For NMR analyses, CoQ1 was dissolved in DMSO-d6 and 
quantified using extinction coefficient 14.3 mM-1cm-1 at 275 nm.  In the reaction 
(250 µL total volume) with L-T2C, 2 µM SmPutA was mixed with 0.5 mM CoQ1, 
and 0.5 mM L-T2C in 50 mM phosphate buffer (50 mM NaCl, pH 7.5). 20 µL of 
deuterium oxide was added to the reaction mixture as noted above. Reactions 
were initiated by adding SmPutA and quickly transferred to an NMR tube and 
incubated for 60 min at 25 oC during data acquisition. For the reaction with L-T4C, 
SmPutA was first flash-frozen and lyophilized, then resuspended in deuterated 
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water. The 50 mM potassium phosphate buffer (50 mM NaCl, pH 7.5) and L-T4C 
were also prepared in deuterated water. The reaction mixture (250 µL total volume) 
included 0.5 mM CoQ1, 0.5 mM L-T4C and 2 µM SmPutA. Reactions with L-T4C 
were initiated by adding SmPutA and incubated in an NMR tube for 60 min at 25 
oC during data acquisition.  
RESULTS 
Steady-state PRODH Kinetics. The ability of SmPutA to use L-T2C and L-
T4C as substrates was first tested using the PRODH activity assay. SmPutA 
displayed robust PRODH activity with both compounds (Figure 1). The steady-
state kinetic parameters for L-T2C, L-T4C, and L-proline are reported in Table 1. 
The kcat values range 0.7-1.4 s-1 whereas the KM values for the thiazolidine 
carboxylates are about 30-fold lower relative to L-proline. As a result, the catalytic 
efficiencies with L-T2C and L-T4C are about 20-30 times higher than with L-proline. 
These results show that the SmPutA PRODH domain effectively catalyzes the 






Figure 1. PRODH activity with thiazolidine carboxylates. SmPutA (0.25 µM) was 
mixed with (A) L-proline (0-200 mM), (B) L-T2C (0-2.5 mM), and (C) L-T4C (0-3 
mM) as the varied substrate and 0.2 mM CoQ1 as the fixed substrate. The data 
are fit to the Michaelis-Menten equation.  
Table 1.  Steady-state Kinetic Parameters of SmPutA PRODH Activity 
with Thioproline Substrates 
Varied Substrate KM (mM) kcat (s-1) kcat/KM (M-1s-
1) 
L-T2C 0.22 ± 0.05 0.7± 0.1 3000 ± 1600 
L-T4C 0.24 ± 0.08 1.2 ± 0.1 4900 ± 2100 
L-Proline 7.7 ± 1.8 1.4± 0.1 149 ± 41 
Assays used 0.25 µM SmPutA and 0.2 mM CoQ1 and, 0-2.5 mM L-T2C, 0-3 




 A hallmark of PutAs is the ability to catalyze the coupled PRODH/GSALDH 
reaction involving P5C as the intermediate. To test whether the oxidized products 
of L-T2C and L-T4C from the PRODH reaction can be used as substrates by the 
GSALDH domain, coupled activity assays were conducted. Figure 2 shows that in 
contrast to proline, utilization of L-T2C and L-T4C did not result in NADH formation, 
indicating that oxidation of these thiazolidine carboxylates by the PRODH domain 








Figure 2. SmPutA coupled activity. SmPutA (0.25 µM) was mixed 0.2 mM NAD+, 
0.2 mM CoQ1, and proline (20 mM), L-T2C (5 mM) or L-T4C (5 mM). NADH 
formation with L-proline is indicated by an increase in absorbance at 340 nm.  
 
Single-turnover Studies. The rates of L-T2C and L-T4C reduction of SmPutA 
bound-FAD were determined next by rapidly mixing SmPutA with the different 
substrates. All substrates resulted in complete reduction of the bound FAD as 
shown in Figure 3. Reduction of the FAD occurred in two phases, with kobs1 
corresponding to the major amplitude change in the spectrum. The maximum 























observed rate constant for FAD reduction was determined by plotting kobs1 versus 
substrate concentration. As shown in Figure 4 and reported in Table 2, L-T4C 
resulted in the highest maximal observed rate constant (kmax), about 4-fold higher 
than that determined with proline. Thus, L-T2C and L-T4C are facile reducing 
substrates of the FAD in SmPutA.  
 
Figure 3. UV-visible spectra of PutA reduction by thioproline substrates. Reduction 
of PutA (32 µM, after mixing) with 20 mM (after mixing) (A) L-proline, (B) L-T2C 
and (C) L-T4C. Shown in each inset is the fit of the absorbance change at 450 nm 
to a double exponential decay (equation 2). The kobs1 values estimated from the 






Figure 4. Single-turnover kinetics of SmPutA PRODH domain. SmPutA (32 µM, 
after mixing) was mixed with 0-200 mM L-Proline (A), 0-50 mM L-T2C (B), and 0-
100 mM L-T4C (C). Shown is the fit of the data to eq 2 from which the 
parameters kmax and KD were determined.  
 
 
Table 2. Single-turnover Kinetic Constants of SmPutA/PRODH 
Activity 
Varied Substrate kmax (s-1) KD (mM) 
L-Proline 43.4 ± 5.7 48 ± 17 
L-T2C 91.4 ± 10.8 9.1 ± 3.4 
L-T4C 181 ± 19 26 ± 8 
 
 The coupled reaction of SmPutA was then monitored by stopped-flow to test 
whether oxidation of L-T2C and L-T4C lead to formation of NADH under single-











































turnover conditions. Figure 5 shows reduction of FAD and NADH formation 
measured at 450 and 340 nm, respectively. As expected, mixing SmPutA with 
proline causes reduction of FAD and generates NADH, consistent with coupled 
PRODH-GSALDH activity. In contrast, mixing SmPutA with L-T2C and L-T4C 
result only in reduction of FAD with no NADH formation observed. These results 
confirm that the oxidized products of L-T2C and L-T4C are not substrates for the 
GSALDH domain in SmPutA. 
 
Figure 5. Stopped-flow reaction of coupled PRODH-GSALDH activity in SmPutA. 
SmPutA (25 μM, after mixing) was rapidly mixed with 0.2 mM NAD+ and 20 mM L-
proline, L-T2C, or L-T4C. Shown are the changes in concentration for FADox 
(squares) and NADH (open circles) for the reaction of PutA with each substrate. 
No NADH formation is observed with L-T2C and L-T4C.  
 























MS and NMR Analysis of T2C and L-T4C Products. The oxidized products of L-
T2C and L-T4C generated by SmPutA were then characterized by mass 
spectrometry and NMR.  Mass spectrometry data of the reaction of SmPutA with 
L-T4C and L-T2C showed evidence for 2,3-thiazoline-4-carboxylate (or Δ2-T4C, 
m/z 132) and 3,4-thiazoline-2-carboxylate (or Δ4-T2C, m/z 132), respectively 
(Figure 6). L-T4C and L-T2C, which have the same parent 134 m/z, share the 
same oxidized m/z of 132.  The new 132 m/z species is consistent with a hydride 
Figure 6. Mass spectrometry of L-T2C and L-T4C reaction products. (A) L-T4C 
before and (B) after the reaction with SmPutA. (C) DL-T2C before and (D) after 
the reaction with SmPutA. Oxidized products of T4C and T2C are indicated by 
the appearance of the 132 m/z peak. Reaction mixtures contained 2 µM 
SmPutA, 0.5 mM CoQ1, 0.5 mM L-T2C or L-T4C, in 50 mM potassium phosphate 




transfer to the  bound FAD and formation of a double bond during the reaction with 
PutA. Because mass spectrometry did not distinguish at which carbon L-T4C and 
L-T2C are oxidized, NMR was used to further confirm the reaction products. Figure 
7A shows the NMR spectrum of the products from the reaction of PutA and L-T2C. 
The results provide evidence that the C4 atom is oxidized in the reaction (i.e., Δ4-
T2C is the product). Likewise, oxidation of the C2 atom in L-T4C was indicated in 
the NMR spectrum of the reaction with L-T4C (Figure 7B). Because water 
suppression interfered with assignment of the proton at the C4’ position of Δ2-T4C 
at 4.80 ppm, a sample was prepared using only deuterium oxide as the solvent 
and analyzed by COSY NMR.  COSY NMR spectra (Figure S1) shows clear 
assignment of the C4’ proton of Δ2-T4C further confirming Δ2-T4C as the product. 
These results suggest that L-T2C and L-T4C are oxidized by SmPutA in a hydride 
transfer mechanism similar to proline.   
 To test whether PutA mediated oxidation of L-T2C and L-T4C leads to cysteine 
formation, reaction products were incubated with iodoacetamide and analyzed by 
ESI-MS. Figure S3 shows a Cys-CAM species (m/z 179) in the reaction with L-
T4C, indicating cysteine is generated in the reaction. No Cys-CAM was detected 
in reactions with L-T2C; thus, formation of a free sulfur species is unique to 




Figure 7. NMR spectra of T2C and T4C reaction products. (A) Proton NMR 
spectrum of Δ4-T2C after reacting L-T2C and SmPutA for approximately one hour. 
(B) Proton NMR spectrum of Δ2-T4C after reacting L-T4C and SmPutA for 
approximately one hour.  Proton of the C4’ position of Δ2-T4C at 4.80 ppm is not 
visible due to water suppression. NMR spectra of T2C and T4C before addition of 
SmPutA are provided in Figure S2. 
   
DISCUSSION 
 PutA was shown here to readily use L-T2C and L-T4C as substrates for the 
PRODH reaction. Rapid reaction kinetics show the maximum rate of FAD reduction 
is faster with the thiazolidine carboxylate substrates than with L-proline and the 
lower KD values estimated for L-T2C and L-T4C compared to L-proline indicate 
these alternative substrates bind with strong affinity to the PRODH active site. The 
oxidative step was previously determined to be rate-limiting for kcat during catalytic 
turnover for the proline:ubiquinone oxidoreductase activity of PutA.47 Thus, 
although the rate of flavin reduction is higher with T2C and T4C, the overall kcat 
does not increase. The catalytic efficiency of PutA with the thiazolidine 
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carboxylates is significantly higher than with L-proline due to the lower KM values 
for T2C and T4C. L-T2C was shown recently to be a mechanism-based inactivator 
of SmPutA, however, the inactivation is very slow with an apparent pseudo-first 
order rate constant for of 0.44 days–1.38 Thus, inactivation of SmPutA by T2C is 
not expected to occur under the conditions used here for the steady-state and rapid 
reaction experiments. 
 Covalent modification of FAD by L-T2C was observed in crystals of SmPutA 
that were derived from co-crystallization of SmPutA and DL-T2C.38 A crystal 
structure of the inactivated enzyme showed L-T2C forms a covalent bond between 
the C5 of T2C and N5 of reduced FAD.38 The T2C covalent adduct was observed 
to occupy the same site as L-tetrahydro-2-furoic acid (L-THFA), a competitive 
inhibitor that mimics proline binding and ion pairs with active site residues Arg488, 
Arg489, and Lys265 (Figure 8A)38. The structural similarity of L-T2C and L-T4C to 
L-proline suggests that these alternative substrates bind to the PRODH active site 
like L-proline. Manual docking calculations based on the L-THFA complex 
structure (PDB 5KF6) suggest that the C4 of L-T2C and the C2 of L-T4C can 
approach the FAD N5 within 3.2 Å without introducing any steric clashes in the 
structure. For reference, the analogous distance for the L-THFA complex is 3.3 Å. 
These results are consistent with L-T2C and L-T4C binding PRODH like L-THFA 
and proline (see Figure 8A), allowing for hydride transfer from the C4 and C2 atoms 
of L-T2C and L-T4C, respectively, to the FAD N5 in SmPutA. A reaction 
mechanism for the reduction of SmPutA-bound FAD by L-T4C is proposed in 
Figure 8B. The electronegative sulfur atom in the pyrrolidine ring likely increases 
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the acidity of the C4 and C2 atoms in L-T2C and L-T4C, respectively, enabling 
these compounds to be facile reducing substrates of the bound FAD.48 Using the 
software program Chemicalize (http://www.chemaxon.com), pKa values for the 
secondary amine in T4C and T2C were both calculated to be 7.7. The calculated 
value for T4C is higher than the experimentally determined pKa value of 6.24 
reported previously for T4C.49  Thus, L-T2C and L-T4C may already have the 
secondary amine deprotonated in the enzyme bound form due to the much lower 
pKa of the nitrogen atom relative to L-Pro (calculated pKa = 11.3).49, 50 These 
chemical properties may explain why L-T2C and L-T4C are faster reducing 
substrates than proline. 
Figure 9 shows the steps for the non-enzymatic hydrolysis of P5C that leads to 
formation of GSAL, the substrate for the GSALDH domain. An interesting 
observation here is that no formation of NADH is observed with T4C and T2C, 
indicating that unlike P5C, Δ2-T4C and Δ4-T2C are not able to continue along the 
PRODH/GSALDH coupled reaction pathway. It was also noted in the inactivation 
study of SmPutA with T2C that NADH was not generated under single turnover 
conditions.38 In considering possible explanations for the lack of usable substrates 
for GSALDH, we sought to determine whether oxidation of these compounds lead 
to alternative products. We detected cysteine as a reaction product with L-T4C, 
which as depicted in Figure 9, is formed by hydrolysis of Δ2-T4C to N-formyl-
cysteine and subsequently hydrolyzed to release cysteine and formate.11, 51 In 
contrast to T4C, SmPutA oxidation of T2C did not generate other detectable 







Figure 8. Structure of substrate binding site and proposed hydride transfer mechanism. (A) 
Structure L-THFA bound to the PRODH active site in SmPutA (PDB 5KF6).37 Figure 
adapted from Campbell, A. C.; Becker, D. F.; Gates, K. S.; Tanner, J. J. Covalent 
Modification of the Flavin in Proline Dehydrogenase by Thiazolidine-2-Carboxylate. ACS 
Chem. Biol. 2020, 15, 936-944.38 (B) Proposed oxidation mechanism of L-T4C. 

































Figure 9. Predicted pKa values for P5C and thiazolidine carboxylates and 
hydrolysis products. The pKa values for protonation of the nitrogen in P5C, Δ2-T4C 
and Δ4-T2C. Hydrolysis of the protonated species are shown generating GSAL and 
N-formyl-Cys from P5C and Δ2-T4C, respectively. Hydrolysis of N-formyl-Cys to 
generate free cysteine and formaldehyde is not shown. Hydrolysis products from 
Δ4-T2C were not detected. Figure drawn with ChemDraw 20. 
 
 Curious as to why Δ4-T2C appears less susceptible to hydrolysis under the 
assay conditions (pH 7.5), we considered that the sulfur atom may have a 
significant impact on the pKa of the nitrogen. Hydrolysis and ring-opening of P5C 
to form GSAL is favored when the nitrogen is protonated (Figure 9). The pKa values 
of the nitrogen in P5C, Δ2-T4C and Δ4-T2C were thus estimated using the software 
program Chemicalize from ChemAxon (http://www.chemaxon.com). The predicted 
pKa of the nitrogen atom in P5C is 6.1, which is only slightly lower than the 
experimentally determined value of 6.67.52 Surprisingly, the pKa values for the 
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nitrogen atom in Δ2-T4C (pKa 1.8) and Δ4-T2C (pKa 1.5) are predicted to be over 4 
pH units more acidic than that of P5C (Figure 9). This highly suggests that the 
nitrogen is predominantly deprotonated in the enzyme bound forms of Δ2-T4C and 
Δ4-T2C. Thus, hydrolysis may be impeded by the much lower pKa of the nitrogen 
atom in Δ2-T4C and Δ4-T2C (Figure 9). In the case of Δ2-T4C, however, the ring-
opening step that leads to N-formyl-cysteine formation may shift the equilibrium in 
favor of hydrolysis.   
 In conclusion, steady-state and single-turnover kinetic studies provide strong 
evidence that L-T2C and L-T4C are facile substrates of the PRODH active site in 
PutA. The ESI-MS and NMR results support a hydride transfer mechanism leading 
to the oxidized products Δ2-T4C and Δ4-T2C. The carbon-sulfur bond in thioproline 
has been shown to increase the perimeter of the pyrrolidine ring and impact the 
energy levels of different conformers relative to proline.24 This could enhance 
binding of thioproline to the PRODH active site which may be reflected in the lower 
KM and KD values determined for L-T2C and L-T4C. Potentially this would explain 
why L-T4C has been reported to inhibit proline metabolism at concentrations much 
less than proline.53 Another chemical effect of sulfur that likely enhances FAD 
reduction by thioproline is the increased acidity of the nitrogen and adjacent carbon 
atom. Altogether, PutA exhibits efficient catalytic activity with L-T2C and L-T4C, 
thus further implicating PRODH as a key enzyme for lowering intracellular levels 





1.  Phang, J. M.; Liu, W.;  Zabirnyk, O. Proline Metabolism and 
Microenvironmental Stress. Annu. Rev. Nutr. 2010, 30, 441-463. 
2.  Szabados, L.;Savoure, A. Proline: A Multifunctional Amino Acid. Trends 
Plant. Sci. 2010, 15, 89-97. 
3.  Liang, X.; Zhang, L.; Natarajan, S. K.;  Becker, D. F. Proline Mechanisms 
of Stress Survival. Antioxid. Redox Signal. 2013, 19, 998-1011. 
4.  Furlan, A. L.; Bianucci, E.; Giordano, W.; Castro, S.;  Becker, D. F. Proline 
Metabolic Dynamics and Implications in Drought Tolerance of Peanut 
Plants. Plant Physiol. Biochem. 2020, 151, 566-578. 
5.  Christgen, S. L.;Becker, D. F. Role of Proline in Pathogen and Host 
Interactions. Antioxid. Redox Signal. 2019, 30, 683-709. 
6. Holfeld, L.; Knappe, D.;  Hoffmann, R. Proline-Rich Antimicrobial Peptides 
Show a Long-Lasting Post-Antibiotic Effect on Enterobacteriaceae and 
Pseudomonas Aeruginosa. J. Antimicrob. Chemother. 2018, 73, 933-941. 
7.  Li, W.; Tailhades, J.; O'Brien-Simpson, N. M.; Separovic, F.; Otvos, L., Jr.; 
Hossain, M. A.;  Wade, J. D. Proline-Rich Antimicrobial Peptides: Potential 
Therapeutics against Antibiotic-Resistant Bacteria. Amino Acids 2014, 46, 
2287-2294. 
8.  Seefeldt, A. C.; Nguyen, F.; Antunes, S.; Perebaskine, N.; Graf, M.; Arenz, 
S.; Inampudi, K. K.; Douat, C.; Guichard, G.; Wilson, D. N.;  Innis, C. A. 
The Proline-Rich Antimicrobial Peptide Onc112 Inhibits Translation by 
Blocking and Destabilizing the Initiation Complex. Nat. Struct. Mol. Biol. 
2015, 22, 470-475. 
9.  Mardirossian, M.; Barriere, Q.; Timchenko, T.; Muller, C.; Pacor, S.; 
Mergaert, P.; Scocchi, M.;  Wilson, D. N. Fragments of the Nonlytic Proline-
Rich Antimicrobial Peptide Bac5 Kill Escherichia Coli Cells by Inhibiting 
Protein Synthesis. Antimicrob. Agents Chemother. 2018, 62, e00534-
00518. 
10.  Mackenzie, C. G.;Harris, J. N-Formylcysteine Synthesis in Mitochondria 
from Formaldehyde and L-Cysteine Via Thiazolidine Carboxylic Acid. J. 
Biol. Chem. 1957, 227, 393-406. 
11.  Patterson, J. A.; He, H.; Folz, J. S.; Li, Q.; Wilson, M. A.; Fiehn, O.; Bruner, 
S. D.; Bar-Even, A.;  Hanson, A. D. Thioproline Formation as a Driver of 
Formaldehyde Toxicity in Escherichia Coli. Biochem. J. 2020, 477, 1745-
1757. 
12.  Fitzpatrick, P. F.;Massey, V. Thiazolidine-2-Carboxylic Acid, an Adduct of 
Cysteamine and Glyoxylate, as a Substrate for D-Amino Acid Oxidase. J. 
Biol. Chem. 1982, 257, 1166-1171. 
13.  Debey, H. J.; Mackenzie, J. B.;  Mackenzie, C. G. The Replacement by 
Thiazolidine Carboxylic Acid of Exogenous Cystine and Cysteine. J. Nutr. 
1958, 66, 607-619. 
14.  Bohler, S. L-Thiazolidine-4-Carboxylic Acid as a Source of Cysteine in 
Parenteral Nutrition. Infusionstherapie 1988, 15, 52-57. 
89 
 
15.  Ham, Y. H.; Jason Chan, K. K.;  Chan, W. Thioproline Serves as an 
Efficient Antioxidant Protecting Human Cells from Oxidative Stress and 
Improves Cell Viability. Chem. Res. Toxicol. 2020, 33, 1815-1821. 
16.  Weber, H. U.; Fleming, J. F.;  Miquel, J. Thiazolidine-4-Carboxylic Acid, a 
Physiologic Sulfhydryl Antioxidant with Potential Value in Geriatric 
Medicine. Arch. Gerontol. Geriatr. 1982, 1, 299-310. 
17.  Tahira, T.; Tsuda, M.; Wakabayashi, K.; Nagao, M.;  Sugimura, T. Kinetics 
of Nitrosation of Thioproline, the Precursor of a Major Nitroso Compound in 
Human Urine, and Its Role as a Nitrite Scavenger. Gan 1984, 75, 889-894. 
18.  Gosalvez, M. Thioproline and Reversal of Cancer. Lancet 1983, 1, 1108. 
19. Kumagai, H.; Mukaisho, K.; Sugihara, H.; Miwa, K.; Yamamoto, G.;  
Hattori, T. Thioproline Inhibits Development of Esophageal 
Adenocarcinoma Induced by Gastroduodenal Reflux in Rats. 
Carcinogenesis 2004, 25, 723-727. 
20.  Tahira, T.; Ohgaki, H.; Wakabayashi, K.; Nagao, M.;  Sugimura, T. The 
Inhibitory Effect of Thioproline on Carcinogenesis Induced by N-
Benzylmethylamine and Nitrite. Food Chem. Toxicol. 1988, 26, 511-516. 
21.  Brugarolas, A.;Gosalvez, M. Treatment of Cancer by an Inducer of Reverse 
Transformation. Lancet 1980, 1, 68-70. 
22.  Navarro, A.; Sánchez-Pino, M. J.; Gómez, C.; Bández, M. J.; Cadenas, E.;  
Boveris, A. Dietary Thioproline Decreases Spontaneous Food Intake and 
Increases Survival and Neurological Function in Mice. Antioxid. Redox 
Signal. 2007, 9, 131-141. 
23.  Chao, T. F.; Leu, H. B.; Huang, C. C.; Chen, J. W.; Chan, W. L.; Lin, S. J.;  
Chen, S. A. Thiazolidinediones Can Prevent New Onset Atrial Fibrillation in 
Patients with Non-Insulin Dependent Diabetes. Int. J. Cardiol. 2012, 156, 
199-202. 
24.  Ahmed, M.; Ganesan, A.; Wang, F.; Feyer, V.; Plekan, O.;  Prince, K. C. 
Photoelectron Spectra of Some Antibiotic Building Blocks: 2-Azetidinone 
and Thiazolidine-Carboxylic Acid. J. Phys. Chem. A 2012, 116, 8653-8660. 
25.  Budisa, N.; Minks, C.; Medrano, F. J.; Lutz, J.; Huber, R.;  Moroder, L. 
Residue-Specific Bioincorporation of Non-Natural, Biologically Active 
Amino Acids into Proteins as Possible Drug Carriers: Structure and 
Stability of the Per-Thiaproline Mutant of Annexin V. Proc. Natl. Acad. Sci. 
U S A 1998, 95, 455-459. 
26.  Papas, T. S.;Mehler, A. H. Analysis of the Amino Acid Binding to the 
Proline Transfer Ribonucleic Acid Synthetase of Escherichia Coli. J. Biol. 
Chem. 1970, 245, 1588-1595. 
27.  De Marco, C.; Busiello, V.; Di Girolamo, M.;  Cavallini, D. Selenaproline 
and Protein Synthesis. Biochim. Biophys. Acta 1977, 478, 156-166. 
28.  Liu, J.; Hao, C.; Wu, L.; Madej, D.; Chan, W.;  Lam, H. Proteomic Analysis 
of Thioproline Misincorporation in Escherichia Coli. J. Proteomics 2020, 
210, 103541. 
29.  Strecker, H. J. The Preparation of Animal Proline Oxidase Rat Liver., and 
Its Use for the Preparation of Δ1-Pyrroline-5-Carboxylate. Methods 
Enzymol. 1971, 17B, 251-254. 
90 
 
30.  Deutch, C. E. Oxidation of L-Thiazolidine-4-Carboxylate by L-Proline 
Dehydrogenase in Escherichia Coli. J. Gen. Microbiol. 1992, 138 Pt 8, 
1593-1598. 
31.  Deutch, C. E.; Klarstrom, J. L.; Link, C. L.;  Ricciardi, D. L. Oxidation of L-
Thiazolidine-4-Carboxylate by Delta1-Pyrroline-5-Carboxylate Reductase in 
Escherichia Coli. Curr. Microbiol. 2001, 42, 442-446. 
32.  Liu, L. K.; Becker, D. F.;  Tanner, J. J. Structure, Function, and Mechanism 
of Proline Utilization a Puta.. Arch. Biochem. Biophys. 2017, 632, 142-157. 
33.  Wanduragala, S.; Sanyal, N.; Liang, X.;  Becker, D. F. Purification and 
Characterization of Put1p from Saccharomyces Cerevisiae. Arch. Biochem. 
Biophys. 2010, 498, 136-142. 
34.  Adams, E.;Frank, L. Metabolism of Proline and the Hydroxyprolines. Annu. 
Rev. Biochem. 1980, 49, 1005-1061. 
35.  Tanner, J. J. Structural Biology of Proline Catabolism. Amino Acids 2008, 
35, 719-730. 
36.  Tanner, J. J. Structural Biology of Proline Catabolic Enzymes. Antioxid. 
Redox Signal. 2019, 30, 650-673. 
37.  Luo, M.; Gamage, T. T.; Arentson, B. W.; Schlasner, K. N.; Becker, D. F.;  
Tanner, J. J. Structures of Proline Utilization a Puta. Reveal the Fold and 
Functions of the Aldehyde Dehydrogenase Superfamily Domain of 
Unknown Function. J. Biol. Chem. 2016, 291, 24065-24075. 
38.  Campbell, A. C.; Becker, D. F.; Gates, K. S.;  Tanner, J. J. Covalent 
Modification of the Flavin in Proline Dehydrogenase by Thiazolidine-2-
Carboxylate. ACS Chem. Biol. 2020, 15, 936-944. 
39.  Williams, I.;Frank, L. Improved Chemical Synthesis and Enzymatic Assay 
of Delta-1-Pyrroline-5-Carboxylic Acid. Anal. Biochem. 1975, 64, 85-97. 
40.  Becker, D. F.;Thomas, E. A. Redox Properties of the Puta Protein from 
Escherichia Coli and the Influence of the Flavin Redox State on Puta-DNA 
Interactions. Biochemistry 2001, 40, 4714-4721. 
41.  Degli Esposti, M.; Ferri, E.;  Lenaz, G. Spectroscopic Properties of 
Ubiquinones in Model Systems. Ital. J. Biochem. 1981, 30, 437-452. 
42.  Moxley, M. A.; Tanner, J. J.;  Becker, D. F. Steady-State Kinetic 
Mechanism of the Proline:Ubiquinone Oxidoreductase Activity of Proline 
Utilization a Puta. from Escherichia Coli. Arch. Biochem. Biophys. 2011, 
516, 113-120. 
43.  Michaelis, L.; Menten, M. L.; Johnson, K. A.;  Goody, R. S. The Original 
Michaelis Constant: Translation of the 1913 Michaelis-Menten Paper. 
Biochemistry 2011, 50, 8264-8269. 
44.  Arentson, B. W.; Luo, M.; Pemberton, T. A.; Tanner, J. J.;  Becker, D. F. 
Kinetic and Structural Characterization of Tunnel-Perturbing Mutants in 
Bradyrhizobium Japonicum Proline Utilization A. Biochemistry 2014, 53, 
5150-5161. 
45.  Patil, P. V.;Ballou, D. P. The Use of Protocatechuate Dioxygenase for 
Maintaining Anaerobic Conditions in Biochemical Experiments. Anal. 
Biochem. 2000, 286, 187-192. 
91 
 
46.  Southan, C.;Stracz, A. Extracting and Connecting Chemical Structures 
from Text Sources Using Chemicalize.Org. J. Cheminform. 2013, 5, 20. 
47.  Moxley, M. A.;Becker, D. F. Rapid Reaction Kinetics of Proline 
Dehydrogenase in the Multifunctional Proline Utilization a Protein. 
Biochemistry 2012, 51, 511-520. 
48.  Howardlock, H. E.; Lock, C. J. L.; Martins, M. L.; Smalley, P. S.;  Bell, R. A. 
Amino-Acid Zwitterion Equilibria - Vibrational and Nuclear-Magnetic-
Resonance Studies of Methyl-Substituted Thiazolidine-4-Carboxylic Acids. 
Can. J. Chem. 1986, 64, 1215-1219. 
49.  Ratner, S.;Clarke, H. The Action of Formaldehyde Upon Cysteine. J. Am. 
Chem. Soc. 1937, 59, 200-206. 
50.  Parthasarathy, R.; Paul, B.;  Korytnyk, W. X-Ray and Nmr Studies on 
Thiazolidines: Crystal Structure and Conformational Equilibriums of N-
Acetyl-2-P-Tolyl. Thiazolidine-4-Carboxylic Acid and Related Thiazolidine 
Derivatives. J. Am. Chem. Soc. 1976, 98, 6634-6643. 
51.  Jeelani, G.; Sato, D.; Soga, T.; Watanabe, H.;  Nozaki, T. Mass 
Spectrometric Analysis of L-Cysteine Metabolism: Physiological Role and 
Fate of L-Cysteine in the Enteric Protozoan Parasite Entamoeba 
Histolytica. mBio 2014, 5, e01995. 
52.  Bearne, S. L.;Wolfenden, R. Glutamate Gamma-Semialdehyde as a 
Natural Transition State Analogue Inhibitor of Escherichia Coli 
Glucosamine-6-Phosphate Synthase. Biochemistry 1995, 34, 11515-
11520. 
53.  Elthon, T. E.;Stewart, C. R. Effects of the Proline Analog L-Thiazolidine-4-





APPENDEX A: SUPPORTING INFORMATION 
 
 
Figure S1. COSY NMR Spectra of SmPutA reaction with L-T4C. Reaction mixture (250 
µL total volume) was prepared using deuterium oxide as the solvent, including 0.5 mM 
CoQ1, 0.5 mM L-T4C and 2 µM SmPutA was incubated for 60 min at 25 oC.  








Figure S2. NMR spectra of unreacted T2C and T4C mixtures. (A) Proton NMR spectrum 
of DL-T2C reaction mixture before addition of SmPutA. (B) Proton NMR spectrum of L-








Figure S3. Electrospray ionization mass spectrometry (ESI-MS)  detection of cysteine 
from SmPutA and L-T4C. SmPutA (2 µM) was mixed with 0.5 mM L-T4C or L-T2C and 
0.5 mM CoQ1 in 50 mM potassium phosphate buffer (50 mM NaCl, pH 7.5).Reaction 
mixtures were incubated for 60 min at 23 °C after which 1 mM iodoacetamide (final 
concentration after mixing) was added to each sample and the samples were incubated for 
an additional 10 min at 37 °C to allow for alkylation of thiol species. (A) MS/MS spectra 
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of a control reaction of cysteine + iodoacetamide. (B)  MS/MS spectra of carbamoylated 
derivatives of cysteine from the reaction of SmPutA and L-T4C. (C) MS/MS spectra 
from the reaction of SmPutA and L-T2C. Mass spectra data were analyzed with Analyst 
version 1.6.1 and plotted using SigmaPlot 14.0. The major fragment peaks for Cys-CAM 






Chapter 4.  Insights into substrate channeling of proline utilization A (PutA) 
in Sinorhizobium meliloti 
Abstract 
Proline utilization A (PutA) is a bifunctional enzyme consisting of proline 
dehydrogenase (PRODH) and ∆1-pyrroline-5-carboxylate (P5C) dehydrogenase 
(P5CDH/GSALDH) domains responsible for the first step of proline oxidization to 
P5C and consecutively to glutamate. Substrate channeling have many beneficial 
effects by increasing catalytic efficiency, reducing transition time and intermediate 
toxicity, and preventing competing reactions in the cell. To further investigate 
substrate channeling in enzymes, we examined the kinetics of PutA from 
Sinorhizobium meliloti (SmPutA) and a few SmPutA variants, including tunnel-
blocking mutant SmPutA Asn999Tyr, monofunctional SmPutA Arg489Met and 
SmPutA Cys844Ala as potential non-channeling control pairs. Intriguingly, 
although the Asn999Tyr mutant locates in the middle of the tunnel, the GSALDH 
activity is decreased by 10-fold. Furthermore, the mixture of both monofunctional 
mutants showed channeling activity comparable to that of wildtype SmPutA. These 
results suggest that the oligomerization state could contribute to channeling 
thereby preventing leakage of the intermediate P5C between protomers of the 
dimer, which has not been previously observed in other PutAs.  
 
Introduction 
Substrate channeling is defined as the direct transfer of an intermediate product 
from one active site to another inside the enzyme without leaking of it to the bulk 
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media1. Substrate channeling happens not only in multifunctional enzymes but 
also among monofunctional enzymes that share metabolic intermediates. When a 
series of related metabolic enzymes associate, they form a complex called a 
metabolon, which allows substrate channeling to occur between enzymes of the 
complex2. Substrate channeling has multiple cellular and enzymatic benefits. By 
direct transfer of the intermediate, it facilitates the transfer process. At the same 
time, the substrate concentration at the consecutive active sites is higher than the 
bulk media and increases the catalytic velocity. Also, if the intermediate is toxic, 
substrate channeling reduces its toxicity of the intermediate. The process also 
prevents any competing reactions from taking place1.  
Proline metabolism is an important pathway and involves many critical cellular 
activities, including cellular bioenergetics, redox homeostasis, stress response, 
osmoprotection, and bacterial pathogenesis3–8. Δ1-pyrroline-5-carboxylic acid 
(P5C) is the first product of proline catabolism9. However, P5C is toxic to cells10,11. 
Accordingly, substrate channeling was found in the bifunctional enzyme proline 
utilization A (PutA), which possesses both proline dehydrogenase (PRODH) and 
glutamate-gamma-semialdehyde dehydrogenase (GSALDH) activity12–15. The 
bifunctional PutAs are typically found in Gram-negative bacteria9. In higher-level 
organisms like plants and animals, the PRODH and GSALDH are expressed as 
separate polypeptides9. However, there is evidence showing that the PRODH and 
GSALDH can assemble together to form a complex that channels P5C between 




Figure 1. Domain structure, classification, and three representative oligomerization 
states of PutAs. Figure adapted and edited from “Structure and characterization of 
a class 3B proline utilization A: Ligand-induced dimerization and importance of the 
C-terminal domain for catalysis,” by D. A. Korasick, et al., 2017, Journal of 
Biological Chemistry, 292(3), 9652-9665. Copyright 2017 by The American Society 
for Biochemistry and Molecular Biology, Inc. (A) Domain structure of type A, B, and 
C PutA. (B) classification of PutAs. (C) 3 representative oligomerization states of 
PutAs. Abbreviations: ALDHSF for aldehyde dehydrogenase super family, 
GSALDH for glutamate-gamma-semialdehyde dehydrogenase, PRODH for 
proline dehydrogenase, BjPutA, CfPutA, GsPutA, SmPutA for proline utilization A 
from Bradyrhizobium japonicum, Corynebacterium freiburgense, Geobacter 
sulfurreducens, and Salmonella typhimurium. 
 
Even though there are studies of the channeling properties of PutAs from 
Bradyrhizobium japonicum15, Corynebacterium freiburgense17, Geobacter 
sulfurreducens14, and Salmonella typhimurium12, the architecture, oligomerization 
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state, and quaternary structure of PutA varies between different species. In this 
study, we are using the PutA from Sinorhizobium meliloti (SmPutA) as a model 
protein for substrate channeling studies. SmPutA is a type1A PutA possessing 
PRODH, GSALDH, and an additional aldehyde dehydrogenase superfamily 
(ALDHSF) domain (Figure 1).  SmPutA forms a homodimer with a large interface 
(Figure 1C) and has a 40 Å tunnel that links the PRODH and GSALDH active sites. 
A recent structure of SmPutA showed that in the middle of the channel, Asn999 is 
positioned along the wall of the tunnel. Asn999 was thus mutated to Tyr in an 
attempt to block the channel. Since P5C is non-enzymatically hydrolyzed to 
glutamate-5-semialdehyde (GSAL) before being oxidized to glutamate at the 
GSALDH active site, we hypothesized that the N999Y mutant will block the 
P5C/GSAL intermediate.  
To assess the impact of the Asn999Tyr mutant on substrate channeling, here 
we purified and characterized the SmPutA N999Y mutant by steady-state and 
stopped-flow kinetics. To aid our assessment of substrate channeling in SmPutA, 
we also characterized separate SmPutA mutants R489M and C844A that are 
anticipated to be devoid of PRODH and GSALDH activity, respectively.  These 
mutants enabled us to study substrate channeling using an equal mixture of 
monofunctional SmPutAs (i.e., R489M and C844A) that are able to catalyze the 
overall conversion of L-proline to L-glutamate without necessarily using a 
channeling mechanism. Unexpectedly, the mixture of the R498M and C844A 
monofunctional SmPutA mutants exhibited substrate channeling activity similar to 




Material and Method 
SmPutA R489M, C844A, and N999Y mutant constructs were purchased from 
GenScript using pNIC28-BSA4 WT SmPutA as the template. All chemicals and 
buffers were purchased from Fisher Scientific and Sigma-Aldrich, unless otherwise 
noted. DL-P5C was synthesized according to the method of Williams and Frank 
and stored in 1 M HCl at 4 oC18. P5C concentrations were determined by adding 
o-aminobenzaldehyde (o-AB) and measuring the absorbance at 443 nm (ε443 nm = 
2590 M-1 cm-1)18. 
Purification of WT SmPutA and SmPutA variants 
      WT SmPutA, N999Y, R489M, and C844A SmPutA mutants were expressed in 
Escherichia coli BL21(DE3) pLysS using the pNIC28 expression vector as 
previously described with minor modifications19,20. A 5-mL overnight culture grown 
in LB was used to inoculate a 2 L TB culture. BL21(DE3) cells were grown at 37 
˚C until an OD600 of 0.8, for WT and N999Y SmPutA, the protein expression was 
induced with 0.25 mM IPTG for 10 h at 18 ˚C. R489M and C844A SmPutA were 
induced with 1 mM IPTG for 16 h at 16 ˚C. The cells for WT and N999Y SmPutA 
purification were harvested and then resuspended (1:10 ratio of wet cell mass to 
buffer volume) in 50 mM Tris buffer (pH 7.8) containing 300 mM NaCl, 5 mM 
imidazole, 5% glycerol, five protease inhibitors (3 mM ε-amino-N-caproic acid, 0.3 
mM phenylmethylsulfonyl fluoride, 1.2 µM leupeptin, 48 µM tosyl phenylalanyl 
chloromethyl ketone, and 78 µM tosyllysine chloromethyl 47 ketone hydrochloride), 
20 µM FAD and 0.2% Triton-100; for R489M and C844A purification, the 5 mM 
IMD in the resuspension buffer was removed. Resuspended cells were lysed on 
ice via sonication using a model 550 Sonic Dismembrator (Fisher Scientific) with 
an amplitude power setting of 5 for a total of 5 min using a pulse sequence of 5 s 
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on and 15 s off. Cell lysed material was centrifuged at 20,000 g using a JA 20 rotor 
for 30 min and the supernatant was collected. The supernatant was passed 
through a 0.22 µm filter before loading onto a HisPur Ni-NTA Superflow Agarose 
(Thermo Fisher Scientific) packed in a borosilicate glass column. The flow-through 
was loaded back onto the column again before washing to enhance protein binding 
to the column and protein yield. Protein was eluted step-wise using binding buffer 
with increasing imidazole concentrations (10 mM, 40 mM, and 300 mM). The 
eluted SmPutA was collected in 2 mL fractions, and SDS-PAGE under reducing 
conditions was used to determine the purity of the fractions. The selected fractions 
were pooled and dialyzed at 4˚C against dialysis buffer (50 mM Tris, 150 mM NaCl, 
0.5 mM EDTA, 0.5 mM tris(hydroxypropyl)phosphine (THPP), 10% glycerol, pH 
7.8). The dialyzed protein was then concentrated in an Amicon stirred cell using a 
30 kDa molecular weight cut-off ultrafiltration disc from MilliporeSigma. The 
concentrated protein was flash-frozen in 500 µL aliquots and stored at -80 oC. The 
N-terminal hexahistidine tag was retained in purified SmPutA. The concentration 
of PutA was determined using the BCA method (Pierce) and 
spectrophotometrically using a molar extinction coefficient of 12700 M-1cm-1 at 451 
nm21. 
Steady-state PRODH and P5CDH kinetics 
PRODH activity was determined by using DCPIP (2,6-
dichlorophenolindophenol) as the electron acceptor29–31. In brief, 0.1 µM enzyme 
was mixed with 75 µM DCPIP, 0.3 mM phenazine methosulfate (PMS), and proline 
(0-600 mM) in 20 mM Tris-HCl, 10% glycerol (pH 7.5). KM and kcat values were 
obtained by fitting the initial rates to the Michaelis-Menten equation using Prism32. 
For GSALDH activity D,L-P5C stock was neutralized freshly with NaOH and used 
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within 3 h after neutralization. Assay was performed similarly as previously 
described33 by mixing SmPutA enzyme (0.5 µM) with 0.2 mM NAD+ and varied 
concentrations of L-P5C (0 – 3000 µM) in 50 mM phosphate buffer (pH 7.5, 150 
mM NaCl). The concentration of L-P5C is assumed to be 50% of the D,L-P5C 
stock., GSALDH activity was monitored by tracking the formation of NADH (ε340 = 
6.22 mM-1cm-1) 34. Assays were performed in technical triplicates. 
Steady-state PRODH-GSALDH coupled activity assay 
The PRODH-GSALDH coupled activity of SmPutA with L-proline was studied 
as previously described14. The reactions contained 0.25 µM of SmPutA WT or 
variants mixed with 0.2 mM CoQ1 as the electron acceptor, 0.2 mM NAD+, and 20 
mM of L-proline in assay buffer (50 mM potassium phosphate, 25 mM NaCl, pH 
7.5). The coupled activity was measured by monitoring NADH production at 340 
nm (ε340 =6.22 mM-1 cm-1). 
Single-turnover PRODH kinetics 
      All stopped-flow kinetic measurements were conducted with a Hi-Tech 
Scientific SF-61DX2 stopped-flow instrument equipped with a photodiode array 
detector at 23 oC as previously described14,19. Enzyme, buffer, and substrate 
solutions were degassed using 12 cycles of vacuum and nitrogen. All substrate 
solutions were made in 50 mM phosphate buffer (25 mM NaCl, pH 7.5). In addition, 
100 µM protocatechuic acid (PCA) and 0.05 U/mL protocatechuate 3,4-
Dioxygenase (PCD) were included in the substrate solutions to scrub residual 
oxygen22. SmPutA WT, N999Y, R489M, C844A or an equal molar mixture of 
R489M and C844A were rapidly mixed by stopped-flow with an equal volume of 
80 mM proline, 0.4 mM NAD+ (40 mM, 0.2 mM NAD+ after mixing). The reactions 
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were monitored by multiwavelength absorption from 300-700 nm. The absorbance 
over time was fitted to double exponential decay using Prism 9, and kobs was 
reported. 
 
Results and Discussion 
Single-turnover kinetics of SmPutA variants 
The kinetics of substrate channeling activity of WT SmPutA and the N999Y 
mutant was tested by rapid reaction kinetics in which no electron acceptor is 
included in the reaction, therefore only allowing one turnover of the enzyme. Figure 
1A shows the kinetics of proline reduction of the FAD and subsequent formation 
of NADH after a single turnover with WT SmPutA. The rate of FAD reduction 
occurred faster (kobs = 0.349 s-1) than NADH formation (kobs = 0.0568 s-1). Proline 
reduction of FAD for the SmPutA N999Y mutant (kobs = 0.441 s-1) was similar to 
that of WT SmPutA whereas NADH production was significantly slower with a 
linear velocity rate of 2.6*10-8 M s-1. Eventually after 100 sec, the amount of NADH 
produced matched the amount of FAD reduced (Figure 1B).  
Single-turnover kinetics of SmPutA R489M and C844A were also conducted. 
For the R489M mutant, only limited FAD is observed to be reduced (Figure 1C), 
consistent with a critical role for Arg489 in proline binding in the PRODH active site.  
Because P5C formation is severely limited, the amount of NADH produced is very 
low. For the SmPutA C844A mutant, proline reduction occurred within a time scale 
(kobs = 0.426 s-1) similar to that of WT SmPutA (Figure 1D). In contrast to WT 
SmPutA, however, no NADH formation was observed, confirming the essential role 
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of Cys867 for GSALDH activity. Next, an equal mixture of SmPutA mutants R489M 
and C867A were rapidly mixed with proline. Figure 1E shows FAD reduction 
occurs quickly (kobs = 0.441 s-1) while NADH production occurs much more slowly 




Figure 2. Single-turnover kinetics of SmPutA WT and mutant enzymes. All 
reactions were initiated by rapidly mixing SmPutA with 40 mM Proline and 0.2 mM 
NAD+. Shown are the average absorbance traces from three technical replicates 
(± standard error) at 450 nm for FAD reduction (red circles) and 340 nm for NADH 
formation (blue circles) for the reactions with (A) SmPutA WT (40 µM), (B) SmPutA 
N999Y (8 µM), (C) SmPutA R489M (20 µM), (D) SmPutA C844A (20 µM), and (E) 
an equal molar mixture of R489M and C844A (10 µM each, 20 µM total). All 
concentrations of enzymes and substrates are after mixing.  
 


















































































































































Figure 3. The PRODH and GSALDH activity of SmPutA WT (red circle) and N999Y 
(blue circle) mutant. For PRODH activity, SmPutA WT or N999Y (0.1 µM) were 
mixed with L-proline (0-200 mM) as the varied substrate, 0.3 mM PMS as the 
electron acceptor, and 75 µM DCPIP as the reporter dye. For GSALDH activity, 
0.5 µM SmPutA WT or N999Y was mixed with L-P5C (0-3 mM) as the varied 
substrate, 0.2 mM NAD+ as the fixed substrate, and NADH formation was 
monitored at 340 nm for 5 min. The data are fit to the Michaelis-Menten equation, 
and the resulting kinetic parameters are reported in Table 1. 
The steady-state kinetic parameters for PRODH and GSALDH were next 
determined for SmPutA WT and the mutant N999Y. Figure 3A shows the 
Michaelis-Menten plots for PRODH and GSALDH activity with the kinetic 
parameters reported in Table 1. As expected, the N999Y mutant shows similar 
PRODH activity to WT SmPutA with a kcat/KM of 140 M-1s-1 (Table 1). For the 
GSALDH activity of the N999Y mutant, an over 10-fold decrease in kcat/KM (300 M-
1s-1) is observed relative to WT SmPutA (Figure 3B and Table 1), consistent with 
the single-turnover experiments showing a severe deficiency in NADH formation.  
 
 
Figure 4. SmPutA R489M PRODH activity (A) and SmPutA C844A P5CDH activity (B) in 
comparison with WT SmPutA (red circle). The PRODH and P5CDH were conducted as 
earlier described. 
Next, we characterized the steady-state kinetics of PRODH and GSALDH 
activity in the SmPutA monofunctional variants R489M and C867A.  Consistent 
with single-turnover results, SmPutA R489M mutant lacked PRODH activity 
































(Figure 4A) but exhibited GSALDH activity (Figure 4B) that was only 2-fold lower 
(kcat/KM = 1900 M-1s-1) than SmPutA WT (Table 1). The lower kcat/KM value arises 
from a 2.5-fold higher KM for L-P5C in the SmPutA R489M mutant. Conversely, 
SmPutA C867A mutant showed PRODH activity (kcat/KM = 70 M-1s-1) (Figure 4A) 
that was similar to SmPutA WT but was devoid of GSALDH activity (Figure 4B and 
Table 1).  
Table 1 Kinetic parameters of SmPutA variants 
Active site Enzyme kcat (s-1) KM(P5C) (mM) kcat/KM (M-1s-1) 
PRODH 
WT 11.8 ± 0.79 116 ± 25 101 ± 29 
N999Y 11.0 ± 0.56 81 ±13 134 ± 29 
R489M N/A* N/A* 0.48 
C844A 17 ± 2.2 240 ± 69 69 ± 29 
GSALDH 
WT 3.7 ± 0.42 1.06 ± 0.26 3700 ± 1300 
N999Y N/A* N/A* 300 
R489M 5.0 ± 0.36 2.6 ± 0.33 1900 ± 360 
C844A 0.084 ± 0.014 3.7 ± 1.1 23 ± 11 
*Limited by the L-P5C concentration, the L-P5C concentration used in the kinetic assay is 
insufficient to estimate KM and kcat, thus only the kcat/KM can be obtained.  
 
After characterizing the individual catalytic activity of all three SmPutA variants, 
we proceeded to study substrate channeling activity. The SmPutA N999Y mutant 
shows no channeling activity which is likely caused by low GSALDH activity (Figure 
5). Following the reaction for up to 60 min with SmPutA N999Y also did not 
generate NADH (data not shown) demonstrating a complete block in substrate 
channeling. Both the monofunctional R489M and C867A mutants, show no 
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channeling activity as expected due to the lack of either PRODH or GSALDH 
activity (Figure 5). In the reaction mixture containing both monofunctional SmPutA 
variants, however, NADH formation is observed and appears to mimic NADH 
production observed with SmPutA WT (Figure 5). By extrapolating the linear 
portion of NADH formation to the x-axis, no obvious lag time was observed for the 
PRODH-GSALDH coupled activity in assays with SmPutA WT and SmPutA mixed 
variants. 
 
Figure 5. Substrate channeling activity of SmPutA WT and variants. SmPutA 
enzymes (0.5 µM each) were mixed with 40 mM L-proline and 0.2 mM NAD+ and 
the absorbance at 340 nm was recorded for 20 min. Shown are the reaction traces 
for SmPutA WT (blue), N999Y variant (purple), R489M variant (red), C844A 
(green), and an equal molar mixture (0.5 µM each, 1 µM total) of   the R489M and 
C844A variants.  
 
Because the SmPutA mixed variants exhibited PRODH-GSALDH activity that 
was similar to that of SmPutA WT, we estimated the amount of P5C leaked into 
bulk solvent during the substrate channeling assays. In these assays, the amount 
of NADH formed is monitored in the absence and presence of the P5C trapping 
reagent, o-AB. Figure 6 shows o-AB decreases NADH formation to the same 
























extent in both SmPutA WT and the mixed variants. These results suggest the 
availability of the P5C intermediate to the o-AB trapping agent is not increased in 
the mixed variant system.  
 
Figure 6. NADH formation in the presence of a chemical trapping reagent. Coupled 
PRODH-GSALDH activity assays were performed with SmPutA WT (0.5 µM) and 
an equal molar mixture of R489M and C844A (0.5 µM each, 1 µM total). SmPutA 
enzymes were added to assay solutions containing 40 mM L-proline and 0.2 mM 
NAD+ with and without o-AB (4 mM). Shown are the absorbance traces at 340 nm 
for SmPutA (red) and the mixed variants (blue) in the absence (closed symbols) 
and presence (open symbols) of o-AB. The lower NADH formation observed in the 
presence of o-AB indicates trapping of the P5C intermediate. 
 

























Figure 7. Structure of SmPutA. Figure adapted and edited from “Structure and 
characterization of a class 3B proline utilization A: Ligand-induced dimerization 
and importance of the C-terminal domain for catalysis,” by D. A. Korasick, et al., 
2017, Journal of Biological Chemistry, 292(3), 9652-9665. Copyright 2017 by The 
American Society for Biochemistry and Molecular Biology, Inc. 
Asn999 is located in the middle of the main tunnel (see Figure 6). Thus, 
mutation of Asn999 to Tyr is anticipated to generate a significant effect on 
substrate channeling in SmPutA. Indeed, this was the case as observed by steady-
state and single-turnover kinetic studies of the SmPutA N999Y mutant. The 
PRODH activity of SmPutA N999Y is comparable to that of SmPutA WT but the 
GSALDH and substrate channeling activity was severely diminished. Although 
NADH formation is observed with SmPutA N999Y under single-turnover conditions, 
the rate of NADH production is best fit by linear regression indicating a significant 
delay in the transfer of P5C to the GSALDH active site, either partially through the 




exogenous P5C is more than 10-fold lower than SmPutA WT. This result suggests 
that exogenous P5C enters the GSALDH active site via the tunnel. Alternatively, 
the N999Y mutation changes the conformation of the GSALDH active site that 
impedes P5C binding, thus leading to a higher KM, a value for which we were not 
able to estimate. X-ray crystal structure of SmPutA in complex with P5C/GSAL 
could provide insights into how the substrate accesses the GSALDH active site. It 
will also be important to obtain crystal structures of the N999Y mutant to confirm 
blocking of the tunnel and evaluate whether the N999Y mutation causes changes 
in the GSALDH active site that would result in lower activity.  
An unexpected finding from this work was that the equal molar mixture of the 
monofunctional SmPutA mutants R489M and C844A exhibited PRODH-GSALDH 
coupled activity similar to that of SmPutA WT (Figure 5). In previous studies of 
other PutAs, such as PutA from Bradyrhizobium japonicum and E. coli, the mixed 
variants displayed a long lag time (~ 8 min) in coupled PRODH-GSALDH assays 
prior to NADH formation whereas the corresponding WT PutAs showed no 
significant lag in NADH production. What is more, the amount of P5C trapped by 
o-AB in the bulk solvent during coupled PRODH-GSALDH assays is also similar 
between the SmPutA WT and the mixed variants (Figure 6). Why there is a 
discrepancy between the mixed variants of SmPutA and previously studied PutAs 
is not apparent, but it may involve differences in the oligomeric structures of PutAs. 
As shown in Figure 1, the oligomeric state of PutAs is quite different between 
bacterial species. Unlike other PutAs, SmPutA forms a dimeric structure that 
involves an extensive amount of surface area that results in placing the PRODH 
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and GSALDH active sites from different protomers in close proximity to each other. 
This does not occur in other PutAs such as PutA from Geobacter sulfurreducens 
(GsPutA). Thus, SmPutA mixed variants may resemble substrate channeling 
behavior similar to SmPutA WT due to the proximity of the functional active sites 
in the dimer. Additional studies will be required to test this hypothesis such as 
determining the oligomeric states of SmPutA WT and the mixed variants by 
sedimentation velocity to confirm they form a dimer under the same conditions 
used for our kinetic assays. Structures of the mixed variant dimer would also 
confirm the proximity of the two functional active sites. Showing that both the 
tunneling and proximity mechanisms are utilized to protect the P5C/GSAL 
intermediate in SmPutA during catalysis may have important implications for 
proline catabolic enzymes in other organisms. The transfer of the P5C/GSAL 
intermediate between monofunctional enzymes (e.g., human PRODH and 
GSALDH) may rely solely on the proximity of the two active sites in PRODH-
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Chapter 5. Summary 
Proline metabolism lies in the center of many important cellular pathways1–6. 
The first step of proline metabolism is dependent on proline dehydrogenase 
(PRODH). In bacteria, the PRODH is transcribed together with glutamate-gamma-
semialdehyde dehydrogenase (GSALDH/P5CDH) called PutA7. Chapter 1 
provided a broad introduction to proline metabolism, related enzymes, and 
metabolic disorders, as well as enzyme allostery and promiscuity. There is an 
additional DNA-binding domain at the N-terminus of PRODH-PutA in some Gram-
negative bacteria, such as Escherichia coli; thus allowing the PutA cellular 
localization to switch from DNA binding to membrane association by sensing 
cellular proline level8,9. The PutA uses FAD and NAD+ as cofactors connecting 
cellular redox balance to its function. Therefore, the trifunctional PutAs are great 
models for studying functional switching of proteins. 
 Chapter 2 characterized an L1 linker-truncated E. coli PutA mutant (∆50-85 
EcPutA) to elucidate the details of the role of the linker in the functional change of 
PutA. Creation of linkers of different lengths or amino acid substitution will be 
needed to further characterize the linker's role. Pyruvate dehydrogenase/oxidase 
(Pox) is an enzyme that shares a few similarities with EcPutA. Pox is a cytosolic 
enzyme that uses FAD as a cofactor and shifts to the peripheral of the membrane 
upon flavin reduction. A linker region facilitates a conformational change in Pox 
upon reduction of the FAD. Linkers provide conformational flexibility necessary for 
multi-domain proteins. A better understanding of the linker function in PutA may 
benefit the field of protein design.  
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The disruption of proline metabolic regulation is related to many human 
diseases, including certain types of cancer10–16. Thus, the discovery of small 
molecules that activate or inhibit proline metabolic enzymes may have potential 
clinical benefits. T2C and T4C are natural proline analogs and are proposed to be 
oxidized by PRODH but no kinetic characterization has been reported. Chapter 3 
studied the single turn-over and steady-state kinetics of thiol-containing natural 
proline analogs T2C and T4C using SmPutA as a model. Future experiments 
characterizing the kinetics of human PRODH will address the pathophysiological 
relevance of this discovery. Additionally, cell biology studies will provide more 
results relevant to clinical application, including suppression or overexpression of 
PRODH when supplementing T2C and T4C or other proline analogs.  
There is evidence of channeling the intermediate P5C from the PRODH active 
site directly to the GSALDH site within PutA. Therefore, the bifunctionality of it 
becomes an interesting and important model for channeling studies of enzymes 
(Chapter 4). Chapter 4 characterized the tunnel blocking mutant SmPutA N999Y, 
a bifunctional enzyme, to further elucidate the substrate channeling. The results 
suggest that the N999Y mutant at least partially blocked the tunnel in the enzyme. 
And the channeling event between the two protomers of the SmPutA dimer is first 
time observed in PutAs. More studies need to be done to gain insights into the 
channeling mechanism of the SmPutA, to be more specific, Kirsch assay will 
provide solid evidence of dimer-dependent channeling upon titrating non-
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